id	sid	tid	token	lemma	pos
dhrp-37	1	1	2021	2021	NUM
dhrp-37	1	2	,	,	PUNCT
dhrp-37	1	3	vol	vol	NOUN
dhrp-37	1	4	.	.	NOUN
dhrp-37	1	5	1	1	NUM
dhrp-37	1	6	(	(	PUNCT
dhrp-37	1	7	s5	s5	NOUN
dhrp-37	1	8	)	)	PUNCT
dhrp-37	1	9	11	11	NUM
dhrp-37	1	10	-	-	SYM
dhrp-37	1	11	14	14	NUM
dhrp-37	1	12	https://doi.org/10.47488/dhrp.v1is5.37	https://doi.org/10.47488/dhrp.v1is5.37	PROPN
dhrp-37	1	13	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-37	1	14	11	11	NUM
dhrp-37	1	15	©	©	PROPN
dhrp-37	1	16	dhr	dhr	PROPN
dhrp-37	1	17	health	health	PROPN
dhrp-37	1	18	institute	institute	PROPN
dhrp-37	1	19	for	for	ADP
dhrp-37	1	20	research	research	NOUN
dhrp-37	1	21	and	and	CCONJ
dhrp-37	1	22	development	development	NOUN
dhrp-37	1	23	commentary	commentary	NOUN
dhrp-37	1	24	what	what	PRON
dhrp-37	1	25	is	be	AUX
dhrp-37	1	26	the	the	DET
dhrp-37	1	27	definition	definition	NOUN
dhrp-37	1	28	of	of	ADP
dhrp-37	1	29	being	be	AUX
dhrp-37	1	30	fully	fully	ADV
dhrp-37	1	31	vaccinated	vaccinate	VERB
dhrp-37	1	32	?	?	PUNCT
dhrp-37	2	1	should	should	AUX
dhrp-37	2	2	the	the	DET
dhrp-37	2	3	three	three	NUM
dhrp-37	2	4	-	-	PUNCT
dhrp-37	2	5	dose	dose	NOUN
dhrp-37	2	6	vaccination	vaccination	NOUN
dhrp-37	2	7	with	with	ADP
dhrp-37	2	8	the	the	DET
dhrp-37	2	9	mrna	mrna	PROPN
dhrp-37	2	10	vaccines	vaccine	NOUN
dhrp-37	2	11	be	be	VERB
dhrp-37	2	12	the	the	DET
dhrp-37	2	13	new	new	ADJ
dhrp-37	2	14	standard	standard	NOUN
dhrp-37	2	15	?	?	PUNCT
dhrp-37	3	1	sohail	sohail	PROPN
dhrp-37	3	2	rao	rao	PROPN
dhrp-37	3	3	,	,	PUNCT
dhrp-37	3	4	md	md	PROPN
dhrp-37	3	5	,	,	PUNCT
dhrp-37	3	6	ma	ma	PROPN
dhrp-37	3	7	,	,	PUNCT
dhrp-37	3	8	dphil1	dphil1	PROPN
dhrp-37	3	9	,	,	PUNCT
dhrp-37	3	10	2	2	NUM
dhrp-37	3	11	and	and	CCONJ
dhrp-37	3	12	manish	manish	PROPN
dhrp-37	3	13	singh	singh	PROPN
dhrp-37	3	14	,	,	PUNCT
dhrp-37	3	15	md	md	PROPN
dhrp-37	3	16	,	,	PUNCT
dhrp-37	3	17	facs3	facs3	X
dhrp-37	3	18	1	1	NUM
dhrp-37	3	19	executive	executive	ADJ
dhrp-37	3	20	vice	vice	NOUN
dhrp-37	3	21	president	president	NOUN
dhrp-37	3	22	,	,	PUNCT
dhrp-37	3	23	dhr	dhr	PROPN
dhrp-37	3	24	health	health	PROPN
dhrp-37	3	25	,	,	PUNCT
dhrp-37	3	26	5501	5501	NUM
dhrp-37	3	27	s.	s.	PROPN
dhrp-37	3	28	mccoll	mccoll	PROPN
dhrp-37	3	29	road	road	PROPN
dhrp-37	3	30	,	,	PUNCT
dhrp-37	3	31	edinburg	edinburg	PROPN
dhrp-37	3	32	,	,	PUNCT
dhrp-37	3	33	texas	texas	PROPN
dhrp-37	3	34	78539	78539	NUM
dhrp-37	3	35	and	and	CCONJ
dhrp-37	3	36	president	president	PROPN
dhrp-37	3	37	&	&	CCONJ
dhrp-37	3	38	chief	chief	ADJ
dhrp-37	3	39	executive	executive	ADJ
dhrp-37	3	40	officer	officer	NOUN
dhrp-37	3	41	,	,	PUNCT
dhrp-37	3	42	dhr	dhr	PROPN
dhrp-37	3	43	health	health	PROPN
dhrp-37	3	44	institute	institute	PROPN
dhrp-37	3	45	for	for	ADP
dhrp-37	3	46	research	research	PROPN
dhrp-37	3	47	&	&	CCONJ
dhrp-37	3	48	development	development	PROPN
dhrp-37	3	49	,	,	PUNCT
dhrp-37	3	50	5323	5323	NUM
dhrp-37	3	51	s.	s.	PROPN
dhrp-37	3	52	mccoll	mccoll	PROPN
dhrp-37	3	53	road	road	PROPN
dhrp-37	3	54	,	,	PUNCT
dhrp-37	3	55	edinburg	edinburg	PROPN
dhrp-37	3	56	,	,	PUNCT
dhrp-37	3	57	texas	texas	PROPN
dhrp-37	3	58	78539	78539	NUM
dhrp-37	3	59	.	.	PUNCT
dhrp-37	4	1	orcid	orcid	NOUN
dhrp-37	4	2	:	:	PUNCT
dhrp-37	4	3	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-37	4	4	2	2	NUM
dhrp-37	4	5	correspondence	correspondence	NOUN
dhrp-37	4	6	should	should	AUX
dhrp-37	4	7	be	be	AUX
dhrp-37	4	8	addressed	address	VERB
dhrp-37	4	9	to	to	ADP
dhrp-37	4	10	:	:	PUNCT
dhrp-37	4	11	sohail	sohail	PROPN
dhrp-37	4	12	rao	rao	PROPN
dhrp-37	4	13	,	,	PUNCT
dhrp-37	4	14	md	md	PROPN
dhrp-37	4	15	,	,	PUNCT
dhrp-37	4	16	ma	ma	PROPN
dhrp-37	4	17	,	,	PUNCT
dhrp-37	4	18	dphil	dphil	NOUN
dhrp-37	4	19	.	.	PUNCT
dhrp-37	4	20	,	,	PUNCT
dhrp-37	4	21	dhr	dhr	PROPN
dhrp-37	4	22	health	health	PROPN
dhrp-37	4	23	institute	institute	PROPN
dhrp-37	4	24	for	for	ADP
dhrp-37	4	25	research	research	PROPN
dhrp-37	4	26	&	&	CCONJ
dhrp-37	4	27	development	development	PROPN
dhrp-37	4	28	,	,	PUNCT
dhrp-37	4	29	5323	5323	NUM
dhrp-37	4	30	s.	s.	PROPN
dhrp-37	4	31	mccoll	mccoll	PROPN
dhrp-37	4	32	road	road	PROPN
dhrp-37	4	33	,	,	PUNCT
dhrp-37	4	34	edinburg	edinburg	PROPN
dhrp-37	4	35	,	,	PUNCT
dhrp-37	4	36	texas	texas	PROPN
dhrp-37	4	37	78539	78539	NUM
dhrp-37	4	38	.	.	PUNCT
dhrp-37	5	1	tel	tel	ADP
dhrp-37	5	2	:	:	PUNCT
dhrp-37	5	3	(	(	PUNCT
dhrp-37	5	4	956	956	NUM
dhrp-37	5	5	)	)	PUNCT
dhrp-37	5	6	362	362	NUM
dhrp-37	5	7	-	-	SYM
dhrp-37	5	8	2387	2387	NUM
dhrp-37	5	9	.	.	PUNCT
dhrp-37	6	1	e	e	X
dhrp-37	6	2	-	-	NOUN
dhrp-37	6	3	mail	mail	NOUN
dhrp-37	6	4	:	:	PUNCT
dhrp-37	6	5	s.rao@dhr-rgv.com	s.rao@dhr-rgv.com	X
dhrp-37	6	6	3	3	NUM
dhrp-37	6	7	chief	chief	ADJ
dhrp-37	6	8	executive	executive	ADJ
dhrp-37	6	9	officer	officer	NOUN
dhrp-37	6	10	,	,	PUNCT
dhrp-37	6	11	dhr	dhr	PROPN
dhrp-37	6	12	health	health	PROPN
dhrp-37	6	13	,	,	PUNCT
dhrp-37	6	14	5501	5501	NUM
dhrp-37	6	15	s.	s.	PROPN
dhrp-37	6	16	mccoll	mccoll	PROPN
dhrp-37	6	17	road	road	PROPN
dhrp-37	6	18	,	,	PUNCT
dhrp-37	6	19	edinburg	edinburg	PROPN
dhrp-37	6	20	tx	tx	PROPN
dhrp-37	6	21	78539	78539	NUM
dhrp-37	6	22	and	and	CCONJ
dhrp-37	6	23	dhr	dhr	PROPN
dhrp-37	6	24	health	health	PROPN
dhrp-37	6	25	bariatric	bariatric	PROPN
dhrp-37	6	26	&	&	CCONJ
dhrp-37	6	27	metabolic	metabolic	PROPN
dhrp-37	6	28	institute	institute	PROPN
dhrp-37	6	29	,	,	PUNCT
dhrp-37	6	30	5500	5500	NUM
dhrp-37	6	31	raphael	raphael	PROPN
dhrp-37	6	32	drive	drive	PROPN
dhrp-37	6	33	,	,	PUNCT
dhrp-37	6	34	edinburg	edinburg	PROPN
dhrp-37	6	35	,	,	PUNCT
dhrp-37	6	36	tx	tx	PROPN
dhrp-37	6	37	79539	79539	NUM
dhrp-37	6	38	orcid	orcid	NOUN
dhrp-37	6	39	:	:	PUNCT
dhrp-37	6	40	manish	manish	PROPN
dhrp-37	6	41	singh	singh	PROPN
dhrp-37	6	42	:	:	PUNCT
dhrp-37	7	1	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN
dhrp-37	7	2	received	receive	VERB
dhrp-37	7	3	12/10/2021	12/10/2021	NUM
dhrp-37	7	4	accepted	accept	VERB
dhrp-37	7	5	for	for	ADP
dhrp-37	7	6	publication	publication	NOUN
dhrp-37	7	7	12/10/2021	12/10/2021	NUM
dhrp-37	7	8	published	publish	VERB
dhrp-37	7	9	12/10/2021	12/10/2021	NUM
dhrp-37	7	10	keywords	keyword	NOUN
dhrp-37	7	11	:	:	PUNCT
dhrp-37	7	12	covid-19	covid-19	PROPN
dhrp-37	7	13	;	;	PUNCT
dhrp-37	7	14	sars	sar	NOUN
dhrp-37	7	15	-	-	PUNCT
dhrp-37	7	16	cov-2	cov-2	NUM
dhrp-37	7	17	;	;	PUNCT
dhrp-37	7	18	b.1.1.529	b.1.1.529	ADV
dhrp-37	7	19	;	;	PUNCT
dhrp-37	7	20	omicron	omicron	NOUN
dhrp-37	7	21	variant	variant	NOUN
dhrp-37	7	22	;	;	PUNCT
dhrp-37	7	23	cdc	cdc	PROPN
dhrp-37	7	24	:	:	PUNCT
dhrp-37	7	25	canters	canter	NOUN
dhrp-37	7	26	for	for	ADP
dhrp-37	7	27	disease	disease	NOUN
dhrp-37	7	28	control	control	NOUN
dhrp-37	7	29	and	and	CCONJ
dhrp-37	7	30	prevention	prevention	NOUN
dhrp-37	7	31	;	;	PUNCT
dhrp-37	7	32	fda	fda	PROPN
dhrp-37	7	33	:	:	PUNCT
dhrp-37	7	34	u.s	u.s	PROPN
dhrp-37	7	35	.	.	PROPN
dhrp-37	7	36	food	food	PROPN
dhrp-37	7	37	and	and	CCONJ
dhrp-37	7	38	drug	drug	NOUN
dhrp-37	7	39	administration	administration	NOUN
dhrp-37	7	40	;	;	PUNCT
dhrp-37	7	41	pfizer	pfizer	NOUN
dhrp-37	7	42	/	/	SYM
dhrp-37	7	43	biontech	biontech	PROPN
dhrp-37	7	44	;	;	PUNCT
dhrp-37	7	45	moderna	moderna	PROPN
dhrp-37	7	46	;	;	PUNCT
dhrp-37	7	47	jansen	jansen	PROPN
dhrp-37	7	48	despite	despite	SCONJ
dhrp-37	7	49	the	the	DET
dhrp-37	7	50	availability	availability	NOUN
dhrp-37	7	51	of	of	ADP
dhrp-37	7	52	numerous	numerous	ADJ
dhrp-37	7	53	clinically	clinically	ADV
dhrp-37	7	54	effective	effective	ADJ
dhrp-37	7	55	covid-19	covid-19	PROPN
dhrp-37	7	56	vaccines	vaccine	NOUN
dhrp-37	7	57	which	which	PRON
dhrp-37	7	58	have	have	AUX
dhrp-37	7	59	been	be	AUX
dhrp-37	7	60	approved	approve	VERB
dhrp-37	7	61	and/or	and/or	CCONJ
dhrp-37	7	62	authorized	authorize	VERB
dhrp-37	7	63	for	for	ADP
dhrp-37	7	64	use	use	NOUN
dhrp-37	7	65	in	in	ADP
dhrp-37	7	66	humans	human	NOUN
dhrp-37	7	67	,	,	PUNCT
dhrp-37	7	68	mitigating	mitigate	VERB
dhrp-37	7	69	morbidity	morbidity	NOUN
dhrp-37	7	70	and	and	CCONJ
dhrp-37	7	71	mortality	mortality	NOUN
dhrp-37	7	72	associated	associate	VERB
dhrp-37	7	73	with	with	ADP
dhrp-37	7	74	the	the	DET
dhrp-37	7	75	exposure	exposure	NOUN
dhrp-37	7	76	to	to	ADP
dhrp-37	7	77	or	or	CCONJ
dhrp-37	7	78	infection	infection	NOUN
dhrp-37	7	79	with	with	ADP
dhrp-37	7	80	sars	sar	NOUN
dhrp-37	7	81	-	-	PUNCT
dhrp-37	7	82	cov-2	cov-2	PART
dhrp-37	7	83	virus	virus	NOUN
dhrp-37	7	84	remains	remain	VERB
dhrp-37	7	85	an	an	DET
dhrp-37	7	86	elusive	elusive	ADJ
dhrp-37	7	87	global	global	ADJ
dhrp-37	7	88	challenge	challenge	NOUN
dhrp-37	7	89	.	.	PUNCT
dhrp-37	8	1	it	it	PRON
dhrp-37	8	2	is	be	AUX
dhrp-37	8	3	quite	quite	ADV
dhrp-37	8	4	alarming	alarming	ADJ
dhrp-37	8	5	that	that	PRON
dhrp-37	8	6	worldwide	worldwide	ADV
dhrp-37	8	7	,	,	PUNCT
dhrp-37	8	8	over	over	ADP
dhrp-37	8	9	5.2	5.2	NUM
dhrp-37	8	10	million	million	NUM
dhrp-37	8	11	people	people	NOUN
dhrp-37	8	12	have	have	AUX
dhrp-37	8	13	already	already	ADV
dhrp-37	8	14	died	die	VERB
dhrp-37	8	15	as	as	ADP
dhrp-37	8	16	a	a	DET
dhrp-37	8	17	result	result	NOUN
dhrp-37	8	18	of	of	ADP
dhrp-37	8	19	sars	sar	NOUN
dhrp-37	8	20	-	-	PUNCT
dhrp-37	8	21	cov-2	cov-2	NOUN
dhrp-37	8	22	infection	infection	NOUN
dhrp-37	8	23	and	and	CCONJ
dhrp-37	8	24	over	over	ADP
dhrp-37	8	25	8,000	8,000	NUM
dhrp-37	8	26	continue	continue	VERB
dhrp-37	8	27	to	to	PART
dhrp-37	8	28	meet	meet	VERB
dhrp-37	8	29	this	this	DET
dhrp-37	8	30	tragic	tragic	ADJ
dhrp-37	8	31	fate	fate	NOUN
dhrp-37	8	32	every	every	DET
dhrp-37	8	33	day	day	NOUN
dhrp-37	8	34	(	(	PUNCT
dhrp-37	8	35	1	1	NUM
dhrp-37	8	36	)	)	PUNCT
dhrp-37	8	37	.	.	PUNCT
dhrp-37	9	1	in	in	ADP
dhrp-37	9	2	the	the	DET
dhrp-37	9	3	us	us	PROPN
dhrp-37	9	4	,	,	PUNCT
dhrp-37	9	5	over	over	ADP
dhrp-37	9	6	790,000	790,000	NUM
dhrp-37	9	7	have	have	AUX
dhrp-37	9	8	died	die	VERB
dhrp-37	9	9	as	as	ADP
dhrp-37	9	10	a	a	DET
dhrp-37	9	11	result	result	NOUN
dhrp-37	9	12	of	of	ADP
dhrp-37	9	13	covid-19	covid-19	PROPN
dhrp-37	9	14	and	and	CCONJ
dhrp-37	9	15	over	over	ADP
dhrp-37	9	16	1,000	1,000	NUM
dhrp-37	9	17	people	people	NOUN
dhrp-37	9	18	are	be	AUX
dhrp-37	9	19	dying	die	VERB
dhrp-37	9	20	every	every	DET
dhrp-37	9	21	day	day	NOUN
dhrp-37	9	22	as	as	ADP
dhrp-37	9	23	a	a	DET
dhrp-37	9	24	consequence	consequence	NOUN
dhrp-37	9	25	of	of	ADP
dhrp-37	9	26	infection	infection	NOUN
dhrp-37	9	27	with	with	ADP
dhrp-37	9	28	sars	sar	NOUN
dhrp-37	9	29	-	-	PUNCT
dhrp-37	9	30	cov-2	cov-2	PART
dhrp-37	9	31	(	(	PUNCT
dhrp-37	9	32	2	2	NUM
dhrp-37	9	33	)	)	PUNCT
dhrp-37	9	34	.	.	PUNCT
dhrp-37	10	1	in	in	ADP
dhrp-37	10	2	the	the	DET
dhrp-37	10	3	us	us	PROPN
dhrp-37	10	4	,	,	PUNCT
dhrp-37	10	5	three	three	NUM
dhrp-37	10	6	covid-19	covid-19	PROPN
dhrp-37	10	7	vaccines	vaccine	NOUN
dhrp-37	10	8	have	have	AUX
dhrp-37	10	9	been	be	AUX
dhrp-37	10	10	approved	approve	VERB
dhrp-37	10	11	and/or	and/or	CCONJ
dhrp-37	10	12	authorized	authorize	VERB
dhrp-37	10	13	by	by	ADP
dhrp-37	10	14	the	the	DET
dhrp-37	10	15	fda	fda	PROPN
dhrp-37	10	16	and	and	CCONJ
dhrp-37	10	17	the	the	DET
dhrp-37	10	18	cdc	cdc	PROPN
dhrp-37	10	19	(	(	PUNCT
dhrp-37	10	20	table	table	NOUN
dhrp-37	10	21	1	1	NUM
dhrp-37	10	22	)	)	PUNCT
dhrp-37	10	23	.	.	PUNCT
dhrp-37	11	1	using	use	VERB
dhrp-37	11	2	the	the	DET
dhrp-37	11	3	currently	currently	ADV
dhrp-37	11	4	recommended	recommend	VERB
dhrp-37	11	5	criteria	criterion	NOUN
dhrp-37	11	6	,	,	PUNCT
dhrp-37	11	7	as	as	ADP
dhrp-37	11	8	of	of	ADP
dhrp-37	11	9	december	december	PROPN
dhrp-37	11	10	10	10	NUM
dhrp-37	11	11	,	,	PUNCT
dhrp-37	11	12	2021	2021	NUM
dhrp-37	11	13	,	,	PUNCT
dhrp-37	11	14	60.5	60.5	NUM
dhrp-37	11	15	%	%	NOUN
dhrp-37	11	16	(	(	PUNCT
dhrp-37	11	17	>	>	NOUN
dhrp-37	11	18	200,000	200,000	NUM
dhrp-37	11	19	)	)	PUNCT
dhrp-37	11	20	of	of	ADP
dhrp-37	11	21	the	the	DET
dhrp-37	11	22	u.s	u.s	PROPN
dhrp-37	11	23	.	.	PROPN
dhrp-37	11	24	population	population	NOUN
dhrp-37	11	25	has	have	AUX
dhrp-37	11	26	been	be	AUX
dhrp-37	11	27	fully	fully	ADV
dhrp-37	11	28	vaccinated	vaccinate	VERB
dhrp-37	11	29	(	(	PUNCT
dhrp-37	11	30	table	table	NOUN
dhrp-37	11	31	1	1	NUM
dhrp-37	11	32	)	)	PUNCT
dhrp-37	11	33	and	and	CCONJ
dhrp-37	11	34	71.5	71.5	NUM
dhrp-37	11	35	%	%	NOUN
dhrp-37	11	36	have	have	AUX
dhrp-37	11	37	received	receive	VERB
dhrp-37	11	38	at	at	ADV
dhrp-37	11	39	least	least	ADV
dhrp-37	11	40	one	one	NUM
dhrp-37	11	41	dose	dose	NOUN
dhrp-37	11	42	of	of	ADP
dhrp-37	11	43	the	the	DET
dhrp-37	11	44	covid-19	covid-19	PROPN
dhrp-37	11	45	vaccine	vaccine	NOUN
dhrp-37	11	46	(	(	PUNCT
dhrp-37	11	47	2	2	NUM
dhrp-37	11	48	)	)	PUNCT
dhrp-37	11	49	.	.	PUNCT
dhrp-37	12	1	it	it	PRON
dhrp-37	12	2	is	be	AUX
dhrp-37	12	3	perturbing	perturb	VERB
dhrp-37	12	4	that	that	PRON
dhrp-37	12	5	multiple	multiple	ADJ
dhrp-37	12	6	clinical	clinical	ADJ
dhrp-37	12	7	studies	study	NOUN
dhrp-37	12	8	have	have	AUX
dhrp-37	12	9	demonstrated	demonstrate	VERB
dhrp-37	12	10	the	the	DET
dhrp-37	12	11	decline	decline	NOUN
dhrp-37	12	12	in	in	ADP
dhrp-37	12	13	vaccine	vaccine	NOUN
dhrp-37	12	14	protection	protection	NOUN
dhrp-37	12	15	against	against	ADP
dhrp-37	12	16	sars	sar	NOUN
dhrp-37	12	17	-	-	PUNCT
dhrp-37	12	18	cov-2	cov-2	PART
dhrp-37	12	19	infection	infection	NOUN
dhrp-37	12	20	(	(	PUNCT
dhrp-37	12	21	3	3	NUM
dhrp-37	12	22	,	,	PUNCT
dhrp-37	12	23	4	4	NUM
dhrp-37	12	24	)	)	PUNCT
dhrp-37	12	25	.	.	PUNCT
dhrp-37	13	1	a	a	DET
dhrp-37	13	2	large	large	ADJ
dhrp-37	13	3	cohort	cohort	NOUN
dhrp-37	13	4	study	study	NOUN
dhrp-37	13	5	by	by	ADP
dhrp-37	13	6	chemaitelly	chemaitelly	ADV
dhrp-37	13	7	,	,	PUNCT
dhrp-37	13	8	et.al	et.al	PROPN
dhrp-37	13	9	.	.	PROPN
dhrp-37	13	10	,	,	PUNCT
dhrp-37	13	11	using	use	VERB
dhrp-37	13	12	subjects	subject	NOUN
dhrp-37	13	13	who	who	PRON
dhrp-37	13	14	received	receive	VERB
dhrp-37	13	15	pfizer	pfizer	NOUN
dhrp-37	13	16	vaccine	vaccine	NOUN
dhrp-37	13	17	showed	show	VERB
dhrp-37	13	18	that	that	SCONJ
dhrp-37	13	19	in	in	ADP
dhrp-37	13	20	the	the	DET
dhrp-37	13	21	first	first	ADJ
dhrp-37	13	22	two	two	NUM
dhrp-37	13	23	weeks	week	NOUN
dhrp-37	13	24	after	after	ADP
dhrp-37	13	25	the	the	DET
dhrp-37	13	26	first	first	ADJ
dhrp-37	13	27	dose	dose	NOUN
dhrp-37	13	28	of	of	ADP
dhrp-37	13	29	the	the	DET
dhrp-37	13	30	vaccine	vaccine	NOUN
dhrp-37	13	31	,	,	PUNCT
dhrp-37	13	32	vaccine	vaccine	NOUN
dhrp-37	13	33	effectiveness	effectiveness	NOUN
dhrp-37	13	34	against	against	ADP
dhrp-37	13	35	the	the	DET
dhrp-37	13	36	wild	wild	ADJ
dhrp-37	13	37	-	-	PUNCT
dhrp-37	13	38	type	type	NOUN
dhrp-37	13	39	and	and	CCONJ
dhrp-37	13	40	any	any	DET
dhrp-37	13	41	sars	sar	NOUN
dhrp-37	13	42	-	-	PUNCT
dhrp-37	13	43	cov-2	cov-2	PART
dhrp-37	13	44	variant	variant	NOUN
dhrp-37	13	45	was	be	AUX
dhrp-37	13	46	undetectable	undetectable	ADJ
dhrp-37	13	47	(	(	PUNCT
dhrp-37	13	48	3	3	NUM
dhrp-37	13	49	)	)	PUNCT
dhrp-37	13	50	.	.	PUNCT
dhrp-37	14	1	however	however	ADV
dhrp-37	14	2	,	,	PUNCT
dhrp-37	14	3	seven	seven	NUM
dhrp-37	14	4	days	day	NOUN
dhrp-37	14	5	later	later	ADV
dhrp-37	14	6	,	,	PUNCT
dhrp-37	14	7	it	it	PRON
dhrp-37	14	8	increased	increase	VERB
dhrp-37	14	9	to	to	ADP
dhrp-37	14	10	36.8	36.8	NUM
dhrp-37	14	11	%	%	NOUN
dhrp-37	14	12	,	,	PUNCT
dhrp-37	14	13	peaking	peak	VERB
dhrp-37	14	14	at	at	ADP
dhrp-37	14	15	77.5	77.5	NUM
dhrp-37	14	16	%	%	NOUN
dhrp-37	14	17	in	in	ADP
dhrp-37	14	18	the	the	DET
dhrp-37	14	19	four	four	NUM
dhrp-37	14	20	weeks	week	NOUN
dhrp-37	14	21	after	after	ADP
dhrp-37	14	22	the	the	DET
dhrp-37	14	23	second	second	ADJ
dhrp-37	14	24	dose	dose	NOUN
dhrp-37	14	25	.	.	PUNCT
dhrp-37	15	1	interestingly	interestingly	ADV
dhrp-37	15	2	,	,	PUNCT
dhrp-37	15	3	regardless	regardless	ADV
dhrp-37	15	4	of	of	ADP
dhrp-37	15	5	the	the	DET
dhrp-37	15	6	age	age	NOUN
dhrp-37	15	7	group	group	NOUN
dhrp-37	15	8	,	,	PUNCT
dhrp-37	15	9	vaccine	vaccine	NOUN
dhrp-37	15	10	effectiveness	effectiveness	NOUN
dhrp-37	15	11	against	against	ADP
dhrp-37	15	12	the	the	DET
dhrp-37	15	13	wild	wild	ADJ
dhrp-37	15	14	-	-	PUNCT
dhrp-37	15	15	type	type	NOUN
dhrp-37	15	16	sars	sar	NOUN
dhrp-37	15	17	-	-	PUNCT
dhrp-37	15	18	cov-2	cov-2	PUNCT
dhrp-37	15	19	and	and	CCONJ
dhrp-37	15	20	all	all	DET
dhrp-37	15	21	its	its	PRON
dhrp-37	15	22	variants	variant	NOUN
dhrp-37	15	23	(	(	PUNCT
dhrp-37	15	24	including	include	VERB
dhrp-37	15	25	delta	delta	NOUN
dhrp-37	15	26	)	)	PUNCT
dhrp-37	15	27	gradually	gradually	ADV
dhrp-37	15	28	decreased	decrease	VERB
dhrp-37	15	29	after	after	ADP
dhrp-37	15	30	one	one	NUM
dhrp-37	15	31	month	month	NOUN
dhrp-37	15	32	,	,	PUNCT
dhrp-37	15	33	with	with	ADP
dhrp-37	15	34	the	the	DET
dhrp-37	15	35	decline	decline	NOUN
dhrp-37	15	36	accelerating	accelerate	VERB
dhrp-37	15	37	after	after	ADP
dhrp-37	15	38	month	month	NOUN
dhrp-37	15	39	four	four	NUM
dhrp-37	15	40	,	,	PUNCT
dhrp-37	15	41	to	to	ADP
dhrp-37	15	42	only	only	ADV
dhrp-37	15	43	about	about	ADV
dhrp-37	15	44	20	20	NUM
dhrp-37	15	45	%	%	NOUN
dhrp-37	15	46	after	after	ADP
dhrp-37	15	47	five	five	NUM
dhrp-37	15	48	to	to	PART
dhrp-37	15	49	six	six	NUM
dhrp-37	15	50	months	month	NOUN
dhrp-37	15	51	following	follow	VERB
dhrp-37	15	52	the	the	DET
dhrp-37	15	53	second	second	ADJ
dhrp-37	15	54	dose	dose	NOUN
dhrp-37	15	55	(	(	PUNCT
dhrp-37	15	56	3	3	NUM
dhrp-37	15	57	)	)	PUNCT
dhrp-37	15	58	.	.	PUNCT
dhrp-37	16	1	in	in	ADP
dhrp-37	16	2	israel	israel	PROPN
dhrp-37	16	3	,	,	PUNCT
dhrp-37	16	4	levin	levin	PROPN
dhrp-37	16	5	,	,	PUNCT
dhrp-37	16	6	et.al	et.al	PROPN
dhrp-37	16	7	.	.	PROPN
dhrp-37	16	8	,	,	PUNCT
dhrp-37	16	9	studied	study	VERB
dhrp-37	16	10	4,868	4,868	NUM
dhrp-37	16	11	vaccinated	vaccinate	VERB
dhrp-37	16	12	healthcare	healthcare	NOUN
dhrp-37	16	13	workers	worker	NOUN
dhrp-37	16	14	over	over	ADP
dhrp-37	16	15	the	the	DET
dhrp-37	16	16	period	period	NOUN
dhrp-37	16	17	of	of	ADP
dhrp-37	16	18	approximately	approximately	ADV
dhrp-37	16	19	six	six	NUM
dhrp-37	16	20	months	month	NOUN
dhrp-37	16	21	(	(	PUNCT
dhrp-37	16	22	4	4	NUM
dhrp-37	16	23	)	)	PUNCT
dhrp-37	16	24	.	.	PUNCT
dhrp-37	17	1	the	the	DET
dhrp-37	17	2	subjects	subject	NOUN
dhrp-37	17	3	were	be	AUX
dhrp-37	17	4	tested	test	VERB
dhrp-37	17	5	monthly	monthly	ADV
dhrp-37	17	6	for	for	ADP
dhrp-37	17	7	anti	anti	ADJ
dhrp-37	17	8	-	-	ADJ
dhrp-37	17	9	spike	spike	ADJ
dhrp-37	17	10	immunoglobulin	immunoglobulin	NOUN
dhrp-37	17	11	g	g	PROPN
dhrp-37	17	12	(	(	PUNCT
dhrp-37	17	13	igg	igg	PROPN
dhrp-37	17	14	)	)	PUNCT
dhrp-37	17	15	and	and	CCONJ
dhrp-37	17	16	neutralizing	neutralize	VERB
dhrp-37	17	17	antibodies	antibody	NOUN
dhrp-37	17	18	against	against	ADP
dhrp-37	17	19	sars	sar	NOUN
dhrp-37	17	20	-	-	PUNCT
dhrp-37	17	21	cov-2	cov-2	NOUN
dhrp-37	17	22	.	.	PUNCT
dhrp-37	18	1	a	a	DET
dhrp-37	18	2	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-37	18	3	mailto:s.rao@dhr-rgv.com	mailto:s.rao@dhr-rgv.com	PROPN
dhrp-37	18	4	https://orcid.org/0000-0003-4146-3282	https://orcid.org/0000-0003-4146-3282	PROPN
dhrp-37	18	5	dhrp	dhrp	ADJ
dhrp-37	18	6	,	,	PUNCT
dhrp-37	18	7	2021	2021	NUM
dhrp-37	18	8	,	,	PUNCT
dhrp-37	18	9	vol	vol	NOUN
dhrp-37	18	10	.	.	NOUN
dhrp-37	18	11	1	1	NUM
dhrp-37	18	12	(	(	PUNCT
dhrp-37	18	13	s5	s5	NOUN
dhrp-37	18	14	)	)	PUNCT
dhrp-37	18	15	11	11	NUM
dhrp-37	18	16	-	-	SYM
dhrp-37	18	17	14	14	NUM
dhrp-37	18	18	definition	definition	NOUN
dhrp-37	18	19	of	of	ADP
dhrp-37	18	20	fully	fully	ADV
dhrp-37	18	21	vaccinated	vaccinate	VERB
dhrp-37	18	22	?	?	PUNCT
dhrp-37	19	1	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-37	19	2	12	12	NUM
dhrp-37	19	3	©	©	PROPN
dhrp-37	19	4	dhr	dhr	PROPN
dhrp-37	19	5	health	health	PROPN
dhrp-37	19	6	institute	institute	PROPN
dhrp-37	19	7	for	for	ADP
dhrp-37	19	8	research	research	NOUN
dhrp-37	19	9	and	and	CCONJ
dhrp-37	19	10	development	development	NOUN
dhrp-37	19	11	table	table	NOUN
dhrp-37	19	12	1	1	NUM
dhrp-37	19	13	:	:	PUNCT
dhrp-37	19	14	fda	fda	PROPN
dhrp-37	19	15	and	and	CCONJ
dhrp-37	19	16	cdc	cdc	PROPN
dhrp-37	19	17	approved	approve	VERB
dhrp-37	19	18	and/or	and/or	CCONJ
dhrp-37	19	19	authorized	authorize	VERB
dhrp-37	19	20	covid-19	covid-19	PROPN
dhrp-37	19	21	vaccines	vaccine	NOUN
dhrp-37	19	22	in	in	ADP
dhrp-37	19	23	the	the	DET
dhrp-37	19	24	united	united	PROPN
dhrp-37	19	25	states	states	PROPN
dhrp-37	19	26	pfizer	pfizer	PROPN
dhrp-37	19	27	biontech	biontech	NOUN
dhrp-37	19	28	(	(	PUNCT
dhrp-37	19	29	comirnatytm	comirnatytm	PROPN
dhrp-37	19	30	)	)	PUNCT
dhrp-37	19	31	moderna	moderna	PROPN
dhrp-37	19	32	jansen	jansen	PROPN
dhrp-37	19	33	(	(	PUNCT
dhrp-37	19	34	johnson	johnson	PROPN
dhrp-37	19	35	and	and	CCONJ
dhrp-37	19	36	johnson	johnson	PROPN
dhrp-37	19	37	)	)	PUNCT
dhrp-37	19	38	type	type	NOUN
dhrp-37	19	39	of	of	ADP
dhrp-37	19	40	vaccine	vaccine	NOUN
dhrp-37	19	41	mrna	mrna	PROPN
dhrp-37	19	42	mrna	mrna	PROPN
dhrp-37	19	43	viral	viral	ADJ
dhrp-37	19	44	vector	vector	NOUN
dhrp-37	19	45	primary	primary	ADJ
dhrp-37	19	46	series	series	NOUN
dhrp-37	19	47	of	of	ADP
dhrp-37	19	48	immunization	immunization	NOUN
dhrp-37	19	49	two	two	NUM
dhrp-37	19	50	(	(	PUNCT
dhrp-37	19	51	2	2	NUM
dhrp-37	19	52	)	)	PUNCT
dhrp-37	19	53	doses	dose	NOUN
dhrp-37	19	54	21	21	NUM
dhrp-37	19	55	days	day	NOUN
dhrp-37	19	56	apart	apart	ADP
dhrp-37	19	57	two	two	NUM
dhrp-37	19	58	(	(	PUNCT
dhrp-37	19	59	2	2	NUM
dhrp-37	19	60	)	)	PUNCT
dhrp-37	19	61	doses	dose	NOUN
dhrp-37	19	62	28	28	NUM
dhrp-37	19	63	days	day	NOUN
dhrp-37	19	64	apart	apart	ADP
dhrp-37	19	65	one	one	NUM
dhrp-37	19	66	(	(	PUNCT
dhrp-37	19	67	1	1	NUM
dhrp-37	19	68	)	)	PUNCT
dhrp-37	19	69	dose	dose	NOUN
dhrp-37	19	70	approved	approve	VERB
dhrp-37	19	71	(	(	PUNCT
dhrp-37	19	72	age	age	NOUN
dhrp-37	19	73	)	)	PUNCT
dhrp-37	19	74	>	>	SYM
dhrp-37	20	1	16	16	NUM
dhrp-37	20	2	years	year	NOUN
dhrp-37	20	3	no	no	PRON
dhrp-37	20	4	no	no	ADV
dhrp-37	20	5	authorized	authorized	ADJ
dhrp-37	20	6	(	(	PUNCT
dhrp-37	20	7	age	age	NOUN
dhrp-37	20	8	)	)	PUNCT
dhrp-37	20	9	>	>	SYM
dhrp-37	20	10	5	5	NUM
dhrp-37	20	11	years	year	NOUN
dhrp-37	20	12	>	>	SYM
dhrp-37	20	13	18	18	NUM
dhrp-37	20	14	years	year	NOUN
dhrp-37	20	15	>	>	SYM
dhrp-37	20	16	18	18	NUM
dhrp-37	20	17	years	year	NOUN
dhrp-37	20	18	booster	booster	NOUN
dhrp-37	20	19	or	or	CCONJ
dhrp-37	20	20	3rd	3rd	NOUN
dhrp-37	20	21	dose	dose	NOUN
dhrp-37	20	22	>	>	PROPN
dhrp-37	20	23	16	16	NUM
dhrp-37	20	24	years	year	NOUN
dhrp-37	20	25	*	*	PUNCT
dhrp-37	20	26	>	>	X
dhrp-37	20	27	18	18	NUM
dhrp-37	20	28	years	year	NOUN
dhrp-37	20	29	*	*	PUNCT
dhrp-37	20	30	>	>	X
dhrp-37	20	31	18	18	NUM
dhrp-37	20	32	years	year	NOUN
dhrp-37	20	33	*	*	PUNCT
dhrp-37	20	34	*	*	PUNCT
dhrp-37	20	35	current	current	ADJ
dhrp-37	20	36	definition	definition	NOUN
dhrp-37	20	37	of	of	ADP
dhrp-37	20	38	fully	fully	ADV
dhrp-37	20	39	vaccinated	vaccinate	VERB
dhrp-37	20	40	two	two	NUM
dhrp-37	20	41	(	(	PUNCT
dhrp-37	20	42	2	2	NUM
dhrp-37	20	43	)	)	PUNCT
dhrp-37	20	44	weeks	week	NOUN
dhrp-37	20	45	after	after	SCONJ
dhrp-37	20	46	2nd	2nd	PROPN
dhrp-37	20	47	dose	dose	VERB
dhrp-37	20	48	two	two	NUM
dhrp-37	20	49	(	(	PUNCT
dhrp-37	20	50	2	2	NUM
dhrp-37	20	51	)	)	PUNCT
dhrp-37	20	52	weeks	week	NOUN
dhrp-37	20	53	after	after	SCONJ
dhrp-37	20	54	2nd	2nd	PROPN
dhrp-37	20	55	dose	dose	VERB
dhrp-37	20	56	two	two	NUM
dhrp-37	20	57	(	(	PUNCT
dhrp-37	20	58	2	2	NUM
dhrp-37	20	59	)	)	PUNCT
dhrp-37	20	60	weeks	week	NOUN
dhrp-37	20	61	after	after	ADP
dhrp-37	20	62	1st	1st	NOUN
dhrp-37	20	63	dose	dose	PROPN
dhrp-37	20	64	*	*	PUNCT
dhrp-37	20	65	at	at	ADP
dhrp-37	20	66	least	least	ADJ
dhrp-37	20	67	six	six	NUM
dhrp-37	20	68	(	(	PUNCT
dhrp-37	20	69	6	6	NUM
dhrp-37	20	70	)	)	PUNCT
dhrp-37	20	71	months	month	NOUN
dhrp-37	20	72	after	after	SCONJ
dhrp-37	20	73	completing	complete	VERB
dhrp-37	20	74	the	the	DET
dhrp-37	20	75	primary	primary	ADJ
dhrp-37	20	76	series	series	NOUN
dhrp-37	20	77	of	of	ADP
dhrp-37	20	78	immunization	immunization	NOUN
dhrp-37	20	79	*	*	PUNCT
dhrp-37	20	80	*	*	PUNCT
dhrp-37	20	81	at	at	ADP
dhrp-37	20	82	least	least	ADJ
dhrp-37	20	83	two	two	NUM
dhrp-37	20	84	(	(	PUNCT
dhrp-37	20	85	2	2	NUM
dhrp-37	20	86	)	)	PUNCT
dhrp-37	20	87	months	month	NOUN
dhrp-37	20	88	after	after	ADP
dhrp-37	20	89	receiving	receive	VERB
dhrp-37	20	90	the	the	DET
dhrp-37	20	91	first	first	ADJ
dhrp-37	20	92	dose	dose	NOUN
dhrp-37	20	93	of	of	ADP
dhrp-37	20	94	the	the	DET
dhrp-37	20	95	vaccine	vaccine	NOUN
dhrp-37	20	96	very	very	ADV
dhrp-37	20	97	small	small	ADJ
dhrp-37	20	98	cohort	cohort	NOUN
dhrp-37	20	99	of	of	ADP
dhrp-37	20	100	healthcare	healthcare	NOUN
dhrp-37	20	101	workers	worker	NOUN
dhrp-37	20	102	(	(	PUNCT
dhrp-37	20	103	0.4	0.4	NUM
dhrp-37	20	104	%	%	NOUN
dhrp-37	20	105	)	)	PUNCT
dhrp-37	20	106	were	be	AUX
dhrp-37	20	107	diagnosed	diagnose	VERB
dhrp-37	20	108	as	as	ADP
dhrp-37	20	109	having	have	VERB
dhrp-37	20	110	a	a	DET
dhrp-37	20	111	covid-19	covid-19	PROPN
dhrp-37	20	112	breakthrough	breakthrough	NOUN
dhrp-37	20	113	infection	infection	NOUN
dhrp-37	20	114	.	.	PUNCT
dhrp-37	21	1	the	the	DET
dhrp-37	21	2	mean	mean	PROPN
dhrp-37	21	3	igg	igg	PROPN
dhrp-37	21	4	level	level	NOUN
dhrp-37	21	5	during	during	ADP
dhrp-37	21	6	days	day	NOUN
dhrp-37	21	7	four	four	NUM
dhrp-37	21	8	through	through	ADP
dhrp-37	21	9	30	30	NUM
dhrp-37	21	10	after	after	ADP
dhrp-37	21	11	two	two	NUM
dhrp-37	21	12	pfizer	pfizer	NOUN
dhrp-37	21	13	vaccine	vaccine	NOUN
dhrp-37	21	14	doses	dose	NOUN
dhrp-37	21	15	was	be	AUX
dhrp-37	21	16	29.3	29.3	NUM
dhrp-37	21	17	as	as	ADP
dhrp-37	21	18	a	a	DET
dhrp-37	21	19	sample	sample	NOUN
dhrp-37	21	20	-	-	PUNCT
dhrp-37	21	21	to	to	ADP
dhrp-37	21	22	-	-	PUNCT
dhrp-37	21	23	cutoff	cutoff	NOUN
dhrp-37	21	24	ratio	ratio	NOUN
dhrp-37	21	25	.	.	PUNCT
dhrp-37	22	1	igg	igg	PROPN
dhrp-37	22	2	concentrations	concentration	NOUN
dhrp-37	22	3	fell	fall	VERB
dhrp-37	22	4	substantially	substantially	ADV
dhrp-37	22	5	each	each	DET
dhrp-37	22	6	month	month	NOUN
dhrp-37	22	7	and	and	CCONJ
dhrp-37	22	8	had	have	AUX
dhrp-37	22	9	decreased	decrease	VERB
dhrp-37	22	10	by	by	ADP
dhrp-37	22	11	a	a	DET
dhrp-37	22	12	factor	factor	NOUN
dhrp-37	22	13	of	of	ADP
dhrp-37	22	14	18.3	18.3	NUM
dhrp-37	22	15	after	after	ADP
dhrp-37	22	16	six	six	NUM
dhrp-37	22	17	months	month	NOUN
dhrp-37	22	18	.	.	PUNCT
dhrp-37	23	1	similarly	similarly	ADV
dhrp-37	23	2	,	,	PUNCT
dhrp-37	23	3	neutralizing	neutralize	VERB
dhrp-37	23	4	antibody	antibody	NOUN
dhrp-37	23	5	titers	titer	NOUN
dhrp-37	23	6	dropped	drop	VERB
dhrp-37	23	7	by	by	ADP
dhrp-37	23	8	a	a	DET
dhrp-37	23	9	factor	factor	NOUN
dhrp-37	23	10	of	of	ADP
dhrp-37	23	11	3.9	3.9	NUM
dhrp-37	23	12	between	between	ADP
dhrp-37	23	13	the	the	DET
dhrp-37	23	14	peak	peak	NOUN
dhrp-37	23	15	and	and	CCONJ
dhrp-37	23	16	the	the	DET
dhrp-37	23	17	end	end	NOUN
dhrp-37	23	18	of	of	ADP
dhrp-37	23	19	the	the	DET
dhrp-37	23	20	study	study	NOUN
dhrp-37	23	21	but	but	CCONJ
dhrp-37	23	22	declined	decline	VERB
dhrp-37	23	23	more	more	ADV
dhrp-37	23	24	slowly	slowly	ADV
dhrp-37	23	25	from	from	ADP
dhrp-37	23	26	months	month	NOUN
dhrp-37	23	27	3	3	NUM
dhrp-37	23	28	to	to	PART
dhrp-37	23	29	6	6	NUM
dhrp-37	23	30	.	.	PUNCT
dhrp-37	23	31	expressed	express	VERB
dhrp-37	23	32	as	as	ADP
dhrp-37	23	33	a	a	DET
dhrp-37	23	34	50	50	NUM
dhrp-37	23	35	%	%	NOUN
dhrp-37	23	36	neutralizing	neutralizing	ADJ
dhrp-37	23	37	level	level	NOUN
dhrp-37	23	38	,	,	PUNCT
dhrp-37	23	39	the	the	DET
dhrp-37	23	40	mean	mean	ADJ
dhrp-37	23	41	concentration	concentration	NOUN
dhrp-37	23	42	of	of	ADP
dhrp-37	23	43	neutralizing	neutralize	VERB
dhrp-37	23	44	antibodies	antibody	NOUN
dhrp-37	23	45	was	be	AUX
dhrp-37	23	46	557.1	557.1	NUM
dhrp-37	23	47	at	at	ADP
dhrp-37	23	48	the	the	DET
dhrp-37	23	49	peak	peak	NOUN
dhrp-37	23	50	,	,	PUNCT
dhrp-37	23	51	decreasing	decrease	VERB
dhrp-37	23	52	to	to	ADP
dhrp-37	23	53	119.4	119.4	NUM
dhrp-37	23	54	by	by	ADP
dhrp-37	23	55	six	six	NUM
dhrp-37	23	56	months	month	NOUN
dhrp-37	23	57	.	.	PUNCT
dhrp-37	24	1	six	six	NUM
dhrp-37	24	2	months	month	NOUN
dhrp-37	24	3	after	after	ADP
dhrp-37	24	4	the	the	DET
dhrp-37	24	5	second	second	ADJ
dhrp-37	24	6	dose	dose	NOUN
dhrp-37	24	7	,	,	PUNCT
dhrp-37	24	8	neutralizing	neutralize	VERB
dhrp-37	24	9	antibody	antibody	NOUN
dhrp-37	24	10	concentrations	concentration	NOUN
dhrp-37	24	11	were	be	AUX
dhrp-37	24	12	much	much	ADV
dhrp-37	24	13	lower	low	ADJ
dhrp-37	24	14	in	in	ADP
dhrp-37	24	15	men	man	NOUN
dhrp-37	24	16	than	than	ADP
dhrp-37	24	17	in	in	ADP
dhrp-37	24	18	women	woman	NOUN
dhrp-37	24	19	(	(	PUNCT
dhrp-37	24	20	ratio	ratio	NOUN
dhrp-37	24	21	of	of	ADP
dhrp-37	24	22	means	mean	NOUN
dhrp-37	24	23	[	[	X
dhrp-37	24	24	rom	rom	X
dhrp-37	24	25	]	]	X
dhrp-37	24	26	,	,	PUNCT
dhrp-37	24	27	0.64	0.64	NUM
dhrp-37	24	28	)	)	PUNCT
dhrp-37	24	29	,	,	PUNCT
dhrp-37	24	30	those	those	DET
dhrp-37	24	31	65	65	NUM
dhrp-37	24	32	years	year	NOUN
dhrp-37	24	33	and	and	CCONJ
dhrp-37	24	34	older	old	ADJ
dhrp-37	24	35	versus	versus	ADP
dhrp-37	24	36	those	those	DET
dhrp-37	24	37	18	18	NUM
dhrp-37	24	38	to	to	PART
dhrp-37	24	39	44	44	NUM
dhrp-37	24	40	years	year	NOUN
dhrp-37	24	41	(	(	PUNCT
dhrp-37	24	42	rom	rom	NOUN
dhrp-37	24	43	,	,	PUNCT
dhrp-37	24	44	0.58	0.58	NUM
dhrp-37	24	45	)	)	PUNCT
dhrp-37	24	46	,	,	PUNCT
dhrp-37	24	47	and	and	CCONJ
dhrp-37	24	48	immunosuppressed	immunosuppressed	ADJ
dhrp-37	24	49	vaccinees	vaccinee	NOUN
dhrp-37	24	50	(	(	PUNCT
dhrp-37	24	51	rom	rom	NOUN
dhrp-37	24	52	,	,	PUNCT
dhrp-37	24	53	0.30	0.30	NUM
dhrp-37	24	54	)	)	PUNCT
dhrp-37	24	55	.	.	PUNCT
dhrp-37	25	1	from	from	ADP
dhrp-37	25	2	the	the	DET
dhrp-37	25	3	peak	peak	NOUN
dhrp-37	25	4	to	to	ADP
dhrp-37	25	5	the	the	DET
dhrp-37	25	6	end	end	NOUN
dhrp-37	25	7	of	of	ADP
dhrp-37	25	8	the	the	DET
dhrp-37	25	9	study	study	NOUN
dhrp-37	25	10	,	,	PUNCT
dhrp-37	25	11	substantially	substantially	ADV
dhrp-37	25	12	lower	low	ADJ
dhrp-37	25	13	igg	igg	PROPN
dhrp-37	25	14	levels	level	NOUN
dhrp-37	25	15	were	be	AUX
dhrp-37	25	16	tied	tie	VERB
dhrp-37	25	17	to	to	ADP
dhrp-37	25	18	older	old	ADJ
dhrp-37	25	19	age	age	NOUN
dhrp-37	25	20	,	,	PUNCT
dhrp-37	25	21	male	male	ADJ
dhrp-37	25	22	sex	sex	NOUN
dhrp-37	25	23	,	,	PUNCT
dhrp-37	25	24	and	and	CCONJ
dhrp-37	25	25	the	the	DET
dhrp-37	25	26	presence	presence	NOUN
dhrp-37	25	27	of	of	ADP
dhrp-37	25	28	at	at	ADV
dhrp-37	25	29	least	least	ADV
dhrp-37	25	30	two	two	NUM
dhrp-37	25	31	underlying	underlie	VERB
dhrp-37	25	32	chronic	chronic	ADJ
dhrp-37	25	33	conditions	condition	NOUN
dhrp-37	25	34	(	(	PUNCT
dhrp-37	25	35	high	high	ADJ
dhrp-37	25	36	blood	blood	NOUN
dhrp-37	25	37	pressure	pressure	NOUN
dhrp-37	25	38	,	,	PUNCT
dhrp-37	25	39	diabetes	diabetes	NOUN
dhrp-37	25	40	,	,	PUNCT
dhrp-37	25	41	abnormal	abnormal	ADJ
dhrp-37	25	42	cholesterol	cholesterol	NOUN
dhrp-37	25	43	levels	level	NOUN
dhrp-37	25	44	,	,	PUNCT
dhrp-37	25	45	and	and	CCONJ
dhrp-37	25	46	heart	heart	NOUN
dhrp-37	25	47	,	,	PUNCT
dhrp-37	25	48	lung	lung	NOUN
dhrp-37	25	49	,	,	PUNCT
dhrp-37	25	50	kidney	kidney	NOUN
dhrp-37	25	51	,	,	PUNCT
dhrp-37	25	52	or	or	CCONJ
dhrp-37	25	53	liver	liver	NOUN
dhrp-37	25	54	disease	disease	NOUN
dhrp-37	25	55	)	)	PUNCT
dhrp-37	25	56	,	,	PUNCT
dhrp-37	25	57	autoimmune	autoimmune	ADJ
dhrp-37	25	58	disease	disease	NOUN
dhrp-37	25	59	,	,	PUNCT
dhrp-37	25	60	and	and	CCONJ
dhrp-37	25	61	immunosuppression	immunosuppression	NOUN
dhrp-37	25	62	(	(	PUNCT
dhrp-37	25	63	4	4	NUM
dhrp-37	25	64	)	)	PUNCT
dhrp-37	25	65	.	.	PUNCT
dhrp-37	26	1	given	give	VERB
dhrp-37	26	2	these	these	DET
dhrp-37	26	3	clinical	clinical	ADJ
dhrp-37	26	4	observations	observation	NOUN
dhrp-37	26	5	,	,	PUNCT
dhrp-37	26	6	the	the	DET
dhrp-37	26	7	need	need	NOUN
dhrp-37	26	8	for	for	ADP
dhrp-37	26	9	a	a	DET
dhrp-37	26	10	booster	booster	NOUN
dhrp-37	26	11	dose	dose	NOUN
dhrp-37	26	12	of	of	ADP
dhrp-37	26	13	the	the	DET
dhrp-37	26	14	covid-19	covid-19	PROPN
dhrp-37	26	15	vaccine	vaccine	NOUN
dhrp-37	26	16	was	be	AUX
dhrp-37	26	17	being	be	AUX
dhrp-37	26	18	seriously	seriously	ADV
dhrp-37	26	19	contemplated	contemplate	VERB
dhrp-37	26	20	by	by	ADP
dhrp-37	26	21	the	the	DET
dhrp-37	26	22	scientists	scientist	NOUN
dhrp-37	26	23	and	and	CCONJ
dhrp-37	26	24	the	the	DET
dhrp-37	26	25	public	public	ADJ
dhrp-37	26	26	policy	policy	NOUN
dhrp-37	26	27	experts	expert	NOUN
dhrp-37	26	28	.	.	PUNCT
dhrp-37	27	1	israel	israel	PROPN
dhrp-37	27	2	was	be	AUX
dhrp-37	27	3	among	among	ADP
dhrp-37	27	4	the	the	DET
dhrp-37	27	5	first	first	ADJ
dhrp-37	27	6	country	country	NOUN
dhrp-37	27	7	to	to	PART
dhrp-37	27	8	initiate	initiate	VERB
dhrp-37	27	9	the	the	DET
dhrp-37	27	10	booster	booster	NOUN
dhrp-37	27	11	dose	dose	NOUN
dhrp-37	27	12	of	of	ADP
dhrp-37	27	13	pfizer	pfizer	NOUN
dhrp-37	27	14	vaccine	vaccine	NOUN
dhrp-37	27	15	for	for	ADP
dhrp-37	27	16	its	its	PRON
dhrp-37	27	17	citizens	citizen	NOUN
dhrp-37	27	18	who	who	PRON
dhrp-37	27	19	were	be	AUX
dhrp-37	27	20	>	>	X
dhrp-37	27	21	60	60	NUM
dhrp-37	27	22	years	year	NOUN
dhrp-37	27	23	of	of	ADP
dhrp-37	27	24	age	age	NOUN
dhrp-37	27	25	.	.	PUNCT
dhrp-37	28	1	bar	bar	NOUN
dhrp-37	28	2	-	-	PUNCT
dhrp-37	28	3	on	on	ADP
dhrp-37	28	4	,	,	PUNCT
dhrp-37	28	5	et.al	et.al	PROPN
dhrp-37	28	6	.	.	PROPN
dhrp-37	28	7	,	,	PUNCT
dhrp-37	28	8	evaluated	evaluate	VERB
dhrp-37	28	9	over	over	ADP
dhrp-37	28	10	1.1	1.1	NUM
dhrp-37	28	11	million	million	NUM
dhrp-37	28	12	subjects	subject	NOUN
dhrp-37	28	13	over	over	ADP
dhrp-37	28	14	the	the	DET
dhrp-37	28	15	age	age	NOUN
dhrp-37	28	16	of	of	ADP
dhrp-37	28	17	60	60	NUM
dhrp-37	28	18	who	who	PRON
dhrp-37	28	19	had	have	AUX
dhrp-37	28	20	received	receive	VERB
dhrp-37	28	21	the	the	DET
dhrp-37	28	22	booster	booster	NOUN
dhrp-37	28	23	dose	dose	VERB
dhrp-37	28	24	at	at	ADV
dhrp-37	28	25	least	least	ADV
dhrp-37	28	26	five	five	NUM
dhrp-37	28	27	months	month	NOUN
dhrp-37	28	28	after	after	ADP
dhrp-37	28	29	completing	complete	VERB
dhrp-37	28	30	the	the	DET
dhrp-37	28	31	primary	primary	ADJ
dhrp-37	28	32	immunization	immunization	NOUN
dhrp-37	28	33	with	with	ADP
dhrp-37	28	34	the	the	DET
dhrp-37	28	35	pfizer	pfizer	NOUN
dhrp-37	28	36	vaccine	vaccine	NOUN
dhrp-37	28	37	(	(	PUNCT
dhrp-37	28	38	5	5	NUM
dhrp-37	28	39	)	)	PUNCT
dhrp-37	28	40	.	.	PUNCT
dhrp-37	29	1	those	those	PRON
dhrp-37	29	2	who	who	PRON
dhrp-37	29	3	received	receive	VERB
dhrp-37	29	4	the	the	DET
dhrp-37	29	5	booster	booster	NOUN
dhrp-37	29	6	were	be	AUX
dhrp-37	29	7	approximately	approximately	ADV
dhrp-37	29	8	19.5fold	19.5fold	NUM
dhrp-37	29	9	less	less	ADV
dhrp-37	29	10	likely	likely	ADJ
dhrp-37	29	11	to	to	PART
dhrp-37	29	12	develop	develop	VERB
dhrp-37	29	13	severe	severe	ADJ
dhrp-37	29	14	covid-19	covid-19	PROPN
dhrp-37	29	15	as	as	SCONJ
dhrp-37	29	16	compared	compare	VERB
dhrp-37	29	17	to	to	ADP
dhrp-37	29	18	a	a	DET
dhrp-37	29	19	similar	similar	ADJ
dhrp-37	29	20	age	age	NOUN
dhrp-37	29	21	-	-	PUNCT
dhrp-37	29	22	matched	match	VERB
dhrp-37	29	23	controls	control	NOUN
dhrp-37	29	24	who	who	PRON
dhrp-37	29	25	had	have	AUX
dhrp-37	29	26	only	only	ADV
dhrp-37	29	27	received	receive	VERB
dhrp-37	29	28	the	the	DET
dhrp-37	29	29	two	two	NUM
dhrp-37	29	30	dose	dose	ADJ
dhrp-37	29	31	primary	primary	ADJ
dhrp-37	29	32	series	series	NOUN
dhrp-37	29	33	of	of	ADP
dhrp-37	29	34	immunization	immunization	NOUN
dhrp-37	29	35	.	.	PUNCT
dhrp-37	30	1	interestingly	interestingly	ADV
dhrp-37	30	2	,	,	PUNCT
dhrp-37	30	3	booster	booster	NOUN
dhrp-37	30	4	vaccination	vaccination	NOUN
dhrp-37	30	5	not	not	PART
dhrp-37	30	6	only	only	ADV
dhrp-37	30	7	resulted	result	VERB
dhrp-37	30	8	in	in	ADP
dhrp-37	30	9	significant	significant	ADJ
dhrp-37	30	10	reduction	reduction	NOUN
dhrp-37	30	11	in	in	ADP
dhrp-37	30	12	severe	severe	ADJ
dhrp-37	30	13	covid-19	covid-19	PROPN
dhrp-37	30	14	,	,	PUNCT
dhrp-37	30	15	but	but	CCONJ
dhrp-37	30	16	also	also	ADV
dhrp-37	30	17	reduced	reduce	VERB
dhrp-37	30	18	(	(	PUNCT
dhrp-37	30	19	11.3	11.3	NUM
dhrp-37	30	20	-	-	ADJ
dhrp-37	30	21	fold	fold	ADJ
dhrp-37	30	22	)	)	PUNCT
dhrp-37	30	23	sars	sar	NOUN
dhrp-37	30	24	-	-	PUNCT
dhrp-37	30	25	cov-2	cov-2	NOUN
dhrp-37	30	26	infections	infection	NOUN
dhrp-37	30	27	(	(	PUNCT
dhrp-37	30	28	5	5	NUM
dhrp-37	30	29	)	)	PUNCT
dhrp-37	30	30	.	.	PUNCT
dhrp-37	31	1	similar	similar	ADJ
dhrp-37	31	2	results	result	NOUN
dhrp-37	31	3	supporting	support	VERB
dhrp-37	31	4	the	the	DET
dhrp-37	31	5	effectiveness	effectiveness	NOUN
dhrp-37	31	6	of	of	ADP
dhrp-37	31	7	the	the	DET
dhrp-37	31	8	third	third	ADJ
dhrp-37	31	9	dose	dose	NOUN
dhrp-37	31	10	of	of	ADP
dhrp-37	31	11	the	the	DET
dhrp-37	31	12	pfizer	pfizer	NOUN
dhrp-37	31	13	vaccine	vaccine	NOUN
dhrp-37	31	14	in	in	ADP
dhrp-37	31	15	enhancing	enhance	VERB
dhrp-37	31	16	the	the	DET
dhrp-37	31	17	protection	protection	NOUN
dhrp-37	31	18	against	against	ADP
dhrp-37	31	19	sars	sar	NOUN
dhrp-37	31	20	-	-	PUNCT
dhrp-37	31	21	cov-2	cov-2	PART
dhrp-37	31	22	infections	infection	NOUN
dhrp-37	31	23	were	be	AUX
dhrp-37	31	24	also	also	ADV
dhrp-37	31	25	reported	report	VERB
dhrp-37	31	26	by	by	ADP
dhrp-37	31	27	barda	barda	PROPN
dhrp-37	31	28	et	et	PROPN
dhrp-37	31	29	al	al	PROPN
dhrp-37	31	30	.	.	PROPN
dhrp-37	32	1	(	(	PUNCT
dhrp-37	32	2	6	6	NUM
dhrp-37	32	3	)	)	PUNCT
dhrp-37	32	4	.	.	PUNCT
dhrp-37	33	1	based	base	VERB
dhrp-37	33	2	on	on	ADP
dhrp-37	33	3	these	these	DET
dhrp-37	33	4	and	and	CCONJ
dhrp-37	33	5	similar	similar	ADJ
dhrp-37	33	6	clinical	clinical	ADJ
dhrp-37	33	7	observations	observation	NOUN
dhrp-37	33	8	which	which	PRON
dhrp-37	33	9	provided	provide	VERB
dhrp-37	33	10	unequivocal	unequivocal	ADJ
dhrp-37	33	11	evidence	evidence	NOUN
dhrp-37	33	12	underscoring	underscore	VERB
dhrp-37	33	13	the	the	DET
dhrp-37	33	14	effectiveness	effectiveness	NOUN
dhrp-37	33	15	of	of	ADP
dhrp-37	33	16	a	a	DET
dhrp-37	33	17	booster	booster	NOUN
dhrp-37	33	18	dose	dose	NOUN
dhrp-37	33	19	of	of	ADP
dhrp-37	33	20	covid-19	covid-19	PROPN
dhrp-37	33	21	vaccines	vaccine	NOUN
dhrp-37	33	22	in	in	ADP
dhrp-37	33	23	enhancing	enhance	VERB
dhrp-37	33	24	protection	protection	NOUN
dhrp-37	33	25	against	against	ADP
dhrp-37	33	26	sars	sar	NOUN
dhrp-37	33	27	-	-	PUNCT
dhrp-37	33	28	cov-2	cov-2	PART
dhrp-37	33	29	infection	infection	NOUN
dhrp-37	33	30	,	,	PUNCT
dhrp-37	33	31	on	on	ADP
dhrp-37	33	32	august	august	PROPN
dhrp-37	33	33	12	12	NUM
dhrp-37	33	34	,	,	PUNCT
dhrp-37	33	35	2021	2021	NUM
dhrp-37	33	36	,	,	PUNCT
dhrp-37	33	37	fda	fda	PROPN
dhrp-37	33	38	authorized	authorize	VERB
dhrp-37	33	39	a	a	DET
dhrp-37	33	40	3rd	3rd	ADJ
dhrp-37	33	41	dose	dose	NOUN
dhrp-37	33	42	of	of	ADP
dhrp-37	33	43	pfizer	pfizer	NOUN
dhrp-37	33	44	and/or	and/or	CCONJ
dhrp-37	33	45	moderna	moderna	PROPN
dhrp-37	33	46	vaccine	vaccine	NOUN
dhrp-37	33	47	for	for	ADP
dhrp-37	33	48	certain	certain	ADJ
dhrp-37	33	49	immunocompromised	immunocompromise	VERB
dhrp-37	33	50	individuals	individual	NOUN
dhrp-37	33	51	(	(	PUNCT
dhrp-37	33	52	7	7	NUM
dhrp-37	33	53	)	)	PUNCT
dhrp-37	33	54	.	.	PUNCT
dhrp-37	34	1	this	this	DET
dhrp-37	34	2	authorization	authorization	NOUN
dhrp-37	34	3	was	be	AUX
dhrp-37	34	4	limited	limit	VERB
dhrp-37	34	5	to	to	ADP
dhrp-37	34	6	solid	solid	ADJ
dhrp-37	34	7	organ	organ	NOUN
dhrp-37	34	8	transplant	transplant	NOUN
dhrp-37	34	9	recipients	recipient	NOUN
dhrp-37	34	10	or	or	CCONJ
dhrp-37	34	11	those	those	PRON
dhrp-37	34	12	who	who	PRON
dhrp-37	34	13	are	be	AUX
dhrp-37	34	14	diagnosed	diagnose	VERB
dhrp-37	34	15	with	with	ADP
dhrp-37	34	16	conditions	condition	NOUN
dhrp-37	34	17	that	that	PRON
dhrp-37	34	18	are	be	AUX
dhrp-37	34	19	considered	consider	VERB
dhrp-37	34	20	dhrp	dhrp	ADJ
dhrp-37	34	21	,	,	PUNCT
dhrp-37	34	22	2021	2021	NUM
dhrp-37	34	23	,	,	PUNCT
dhrp-37	34	24	vol	vol	NOUN
dhrp-37	34	25	.	.	NOUN
dhrp-37	34	26	1	1	NUM
dhrp-37	34	27	(	(	PUNCT
dhrp-37	34	28	s5	s5	NOUN
dhrp-37	34	29	)	)	PUNCT
dhrp-37	34	30	11	11	NUM
dhrp-37	34	31	-	-	SYM
dhrp-37	34	32	14	14	NUM
dhrp-37	34	33	definition	definition	NOUN
dhrp-37	34	34	of	of	ADP
dhrp-37	34	35	fully	fully	ADV
dhrp-37	34	36	vaccinated	vaccinate	VERB
dhrp-37	34	37	?	?	PUNCT
dhrp-37	35	1	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-37	35	2	13	13	NUM
dhrp-37	35	3	©	©	PROPN
dhrp-37	35	4	dhr	dhr	PROPN
dhrp-37	35	5	health	health	PROPN
dhrp-37	35	6	institute	institute	PROPN
dhrp-37	35	7	for	for	ADP
dhrp-37	35	8	research	research	NOUN
dhrp-37	35	9	and	and	CCONJ
dhrp-37	35	10	development	development	NOUN
dhrp-37	35	11	to	to	PART
dhrp-37	35	12	have	have	VERB
dhrp-37	35	13	an	an	DET
dhrp-37	35	14	equivalent	equivalent	ADJ
dhrp-37	35	15	level	level	NOUN
dhrp-37	35	16	of	of	ADP
dhrp-37	35	17	immunocompromise	immunocompromise	NOUN
dhrp-37	35	18	.	.	PUNCT
dhrp-37	36	1	on	on	ADP
dhrp-37	36	2	november	november	PROPN
dhrp-37	36	3	19	19	NUM
dhrp-37	36	4	,	,	PUNCT
dhrp-37	36	5	2021	2021	NUM
dhrp-37	36	6	,	,	PUNCT
dhrp-37	36	7	cdc	cdc	PROPN
dhrp-37	36	8	modified	modify	VERB
dhrp-37	36	9	the	the	DET
dhrp-37	36	10	authorization	authorization	NOUN
dhrp-37	36	11	allowing	allow	VERB
dhrp-37	36	12	booster	booster	NOUN
dhrp-37	36	13	dose	dose	VERB
dhrp-37	36	14	for	for	ADP
dhrp-37	36	15	all	all	DET
dhrp-37	36	16	adults	adult	NOUN
dhrp-37	36	17	ages	age	NOUN
dhrp-37	36	18	18	18	NUM
dhrp-37	36	19	years	year	NOUN
dhrp-37	36	20	and	and	CCONJ
dhrp-37	36	21	older	old	ADJ
dhrp-37	36	22	who	who	PRON
dhrp-37	36	23	received	receive	VERB
dhrp-37	36	24	a	a	DET
dhrp-37	36	25	pfizer	pfizer	NOUN
dhrp-37	36	26	-	-	PUNCT
dhrp-37	36	27	biontech	biontech	NOUN
dhrp-37	36	28	or	or	CCONJ
dhrp-37	36	29	moderna	moderna	NOUN
dhrp-37	36	30	vaccine	vaccine	NOUN
dhrp-37	36	31	at	at	ADV
dhrp-37	36	32	least	least	ADV
dhrp-37	36	33	six	six	NUM
dhrp-37	36	34	months	month	NOUN
dhrp-37	36	35	after	after	ADP
dhrp-37	36	36	their	their	PRON
dhrp-37	36	37	second	second	ADJ
dhrp-37	36	38	dose	dose	NOUN
dhrp-37	36	39	(	(	PUNCT
dhrp-37	36	40	8)	8)	NUM
dhrp-37	36	41	.	.	PUNCT
dhrp-37	37	1	emergency	emergency	NOUN
dhrp-37	37	2	authorization	authorization	NOUN
dhrp-37	37	3	for	for	ADP
dhrp-37	37	4	pfizer	pfizer	NOUN
dhrp-37	37	5	-	-	PUNCT
dhrp-37	37	6	biontech	biontech	NOUN
dhrp-37	37	7	covid-19	covid-19	PROPN
dhrp-37	37	8	vaccine	vaccine	NOUN
dhrp-37	37	9	was	be	AUX
dhrp-37	37	10	further	far	ADV
dhrp-37	37	11	modified	modify	VERB
dhrp-37	37	12	by	by	ADP
dhrp-37	37	13	the	the	DET
dhrp-37	37	14	fda	fda	PROPN
dhrp-37	37	15	on	on	ADP
dhrp-37	37	16	december	december	PROPN
dhrp-37	37	17	09	09	NUM
dhrp-37	37	18	,	,	PUNCT
dhrp-37	37	19	2021	2021	NUM
dhrp-37	37	20	,	,	PUNCT
dhrp-37	37	21	for	for	ADP
dhrp-37	37	22	the	the	DET
dhrp-37	37	23	pfizer	pfizer	NOUN
dhrp-37	37	24	-	-	PUNCT
dhrp-37	37	25	biontech	biontech	NOUN
dhrp-37	37	26	covid-19	covid-19	PROPN
dhrp-37	37	27	vaccine	vaccine	NOUN
dhrp-37	37	28	allowing	allow	VERB
dhrp-37	37	29	the	the	DET
dhrp-37	37	30	use	use	NOUN
dhrp-37	37	31	of	of	ADP
dhrp-37	37	32	a	a	DET
dhrp-37	37	33	single	single	ADJ
dhrp-37	37	34	booster	booster	NOUN
dhrp-37	37	35	dose	dose	VERB
dhrp-37	37	36	for	for	ADP
dhrp-37	37	37	administration	administration	NOUN
dhrp-37	37	38	to	to	ADP
dhrp-37	37	39	individuals	individual	NOUN
dhrp-37	37	40	16	16	NUM
dhrp-37	37	41	and	and	CCONJ
dhrp-37	37	42	17	17	NUM
dhrp-37	37	43	years	year	NOUN
dhrp-37	37	44	of	of	ADP
dhrp-37	37	45	age	age	NOUN
dhrp-37	37	46	at	at	ADV
dhrp-37	37	47	least	least	ADV
dhrp-37	37	48	six	six	NUM
dhrp-37	37	49	months	month	NOUN
dhrp-37	37	50	after	after	ADP
dhrp-37	37	51	completion	completion	NOUN
dhrp-37	37	52	of	of	ADP
dhrp-37	37	53	primary	primary	ADJ
dhrp-37	37	54	vaccination	vaccination	NOUN
dhrp-37	37	55	with	with	ADP
dhrp-37	37	56	the	the	DET
dhrp-37	37	57	pfizer	pfizer	NOUN
dhrp-37	37	58	-	-	PUNCT
dhrp-37	37	59	biontech	biontech	NOUN
dhrp-37	37	60	covid-19	covid-19	PROPN
dhrp-37	37	61	vaccine	vaccine	NOUN
dhrp-37	37	62	(	(	PUNCT
dhrp-37	37	63	9	9	NUM
dhrp-37	37	64	)	)	PUNCT
dhrp-37	37	65	.	.	PUNCT
dhrp-37	38	1	the	the	DET
dhrp-37	38	2	recent	recent	ADJ
dhrp-37	38	3	identification	identification	NOUN
dhrp-37	38	4	of	of	ADP
dhrp-37	38	5	omicron	omicron	PROPN
dhrp-37	38	6	(	(	PUNCT
dhrp-37	38	7	5.1.1.529	5.1.1.529	NOUN
dhrp-37	38	8	)	)	PUNCT
dhrp-37	38	9	variant	variant	NOUN
dhrp-37	38	10	of	of	ADP
dhrp-37	38	11	sars	sar	NOUN
dhrp-37	38	12	-	-	PUNCT
dhrp-37	38	13	cov-2	cov-2	NUM
dhrp-37	38	14	from	from	ADP
dhrp-37	38	15	southern	southern	ADJ
dhrp-37	38	16	african	african	ADJ
dhrp-37	38	17	nations	nation	NOUN
dhrp-37	38	18	and	and	CCONJ
dhrp-37	38	19	its	its	PRON
dhrp-37	38	20	rapid	rapid	ADJ
dhrp-37	38	21	spread	spread	NOUN
dhrp-37	38	22	across	across	ADP
dhrp-37	38	23	the	the	DET
dhrp-37	38	24	globe	globe	NOUN
dhrp-37	38	25	has	have	AUX
dhrp-37	38	26	alarmed	alarm	VERB
dhrp-37	38	27	the	the	DET
dhrp-37	38	28	scientific	scientific	ADJ
dhrp-37	38	29	community	community	NOUN
dhrp-37	38	30	and	and	CCONJ
dhrp-37	38	31	the	the	DET
dhrp-37	38	32	public	public	ADJ
dhrp-37	38	33	health	health	NOUN
dhrp-37	38	34	experts	expert	NOUN
dhrp-37	38	35	(	(	PUNCT
dhrp-37	38	36	10	10	NUM
dhrp-37	38	37	-	-	SYM
dhrp-37	38	38	12	12	NUM
dhrp-37	38	39	)	)	PUNCT
dhrp-37	38	40	.	.	PUNCT
dhrp-37	39	1	this	this	PRON
dhrp-37	39	2	has	have	AUX
dhrp-37	39	3	also	also	ADV
dhrp-37	39	4	called	call	VERB
dhrp-37	39	5	to	to	PART
dhrp-37	39	6	question	question	VERB
dhrp-37	39	7	the	the	DET
dhrp-37	39	8	efficacy	efficacy	NOUN
dhrp-37	39	9	of	of	ADP
dhrp-37	39	10	the	the	DET
dhrp-37	39	11	existing	exist	VERB
dhrp-37	39	12	covid-19	covid-19	PROPN
dhrp-37	39	13	vaccines	vaccine	NOUN
dhrp-37	39	14	in	in	ADP
dhrp-37	39	15	affording	afford	VERB
dhrp-37	39	16	protection	protection	NOUN
dhrp-37	39	17	against	against	ADP
dhrp-37	39	18	this	this	DET
dhrp-37	39	19	variant	variant	NOUN
dhrp-37	39	20	.	.	PUNCT
dhrp-37	40	1	a	a	DET
dhrp-37	40	2	team	team	NOUN
dhrp-37	40	3	of	of	ADP
dhrp-37	40	4	scientists	scientist	NOUN
dhrp-37	40	5	from	from	ADP
dhrp-37	40	6	the	the	DET
dhrp-37	40	7	africa	africa	PROPN
dhrp-37	40	8	health	health	PROPN
dhrp-37	40	9	research	research	PROPN
dhrp-37	40	10	institute	institute	PROPN
dhrp-37	40	11	tested	test	VERB
dhrp-37	40	12	14	14	NUM
dhrp-37	40	13	plasma	plasma	NOUN
dhrp-37	40	14	samples	sample	NOUN
dhrp-37	40	15	from	from	ADP
dhrp-37	40	16	12	12	NUM
dhrp-37	40	17	participants	participant	NOUN
dhrp-37	40	18	,	,	PUNCT
dhrp-37	40	19	with	with	ADP
dhrp-37	40	20	6	6	NUM
dhrp-37	40	21	having	have	VERB
dhrp-37	40	22	no	no	DET
dhrp-37	40	23	previous	previous	ADJ
dhrp-37	40	24	history	history	NOUN
dhrp-37	40	25	of	of	ADP
dhrp-37	40	26	sars	sar	NOUN
dhrp-37	40	27	-	-	PUNCT
dhrp-37	40	28	cov-2	cov-2	PART
dhrp-37	40	29	infection	infection	NOUN
dhrp-37	40	30	and	and	CCONJ
dhrp-37	40	31	all	all	PRON
dhrp-37	40	32	were	be	AUX
dhrp-37	40	33	previously	previously	ADV
dhrp-37	40	34	vaccinated	vaccinate	VERB
dhrp-37	40	35	with	with	ADP
dhrp-37	40	36	two	two	NUM
dhrp-37	40	37	doses	dose	NOUN
dhrp-37	40	38	of	of	ADP
dhrp-37	40	39	pfizer	pfizer	NOUN
dhrp-37	40	40	/	/	SYM
dhrp-37	40	41	biontech	biontech	NOUN
dhrp-37	40	42	vaccine	vaccine	NOUN
dhrp-37	40	43	(	(	PUNCT
dhrp-37	40	44	13	13	NUM
dhrp-37	40	45	)	)	PUNCT
dhrp-37	40	46	.	.	PUNCT
dhrp-37	41	1	the	the	DET
dhrp-37	41	2	results	result	NOUN
dhrp-37	41	3	showed	show	VERB
dhrp-37	41	4	a	a	DET
dhrp-37	41	5	41	41	NUM
dhrp-37	41	6	-	-	ADJ
dhrp-37	41	7	fold	fold	ADJ
dhrp-37	41	8	decline	decline	NOUN
dhrp-37	41	9	in	in	ADP
dhrp-37	41	10	antibodies	antibody	NOUN
dhrp-37	41	11	generated	generate	VERB
dhrp-37	41	12	by	by	ADP
dhrp-37	41	13	the	the	DET
dhrp-37	41	14	pfizer	pfizer	NOUN
dhrp-37	41	15	vaccine	vaccine	NOUN
dhrp-37	41	16	to	to	PART
dhrp-37	41	17	neutralize	neutralize	VERB
dhrp-37	41	18	the	the	DET
dhrp-37	41	19	omicron	omicron	PROPN
dhrp-37	41	20	variant	variant	NOUN
dhrp-37	41	21	as	as	ADP
dhrp-37	41	22	compared	compare	VERB
dhrp-37	41	23	to	to	ADP
dhrp-37	41	24	the	the	DET
dhrp-37	41	25	delta	delta	NOUN
dhrp-37	41	26	variant	variant	NOUN
dhrp-37	41	27	of	of	ADP
dhrp-37	41	28	sars	sar	NOUN
dhrp-37	41	29	-	-	PUNCT
dhrp-37	41	30	cov-2	cov-2	NOUN
dhrp-37	41	31	.	.	PUNCT
dhrp-37	42	1	interestingly	interestingly	ADV
dhrp-37	42	2	,	,	PUNCT
dhrp-37	42	3	antibodies	antibodie	VERB
dhrp-37	42	4	in	in	ADP
dhrp-37	42	5	the	the	DET
dhrp-37	42	6	blood	blood	NOUN
dhrp-37	42	7	from	from	ADP
dhrp-37	42	8	the	the	DET
dhrp-37	42	9	six	six	NUM
dhrp-37	42	10	volunteers	volunteer	NOUN
dhrp-37	42	11	who	who	PRON
dhrp-37	42	12	had	have	VERB
dhrp-37	42	13	previous	previous	ADJ
dhrp-37	42	14	sars	sar	NOUN
dhrp-37	42	15	-	-	PUNCT
dhrp-37	42	16	cov-2	cov-2	PART
dhrp-37	42	17	infection	infection	NOUN
dhrp-37	42	18	and	and	CCONJ
dhrp-37	42	19	were	be	AUX
dhrp-37	42	20	subsequently	subsequently	ADV
dhrp-37	42	21	vaccinated	vaccinate	VERB
dhrp-37	42	22	were	be	AUX
dhrp-37	42	23	better	well	ADJ
dhrp-37	42	24	able	able	ADJ
dhrp-37	42	25	to	to	PART
dhrp-37	42	26	neutralize	neutralize	VERB
dhrp-37	42	27	the	the	DET
dhrp-37	42	28	virus	virus	NOUN
dhrp-37	42	29	(	(	PUNCT
dhrp-37	42	30	13	13	NUM
dhrp-37	42	31	)	)	PUNCT
dhrp-37	42	32	.	.	PUNCT
dhrp-37	43	1	the	the	DET
dhrp-37	43	2	possibility	possibility	NOUN
dhrp-37	43	3	of	of	ADP
dhrp-37	43	4	immune	immune	ADJ
dhrp-37	43	5	evasion	evasion	NOUN
dhrp-37	43	6	by	by	ADP
dhrp-37	43	7	the	the	DET
dhrp-37	43	8	omicron	omicron	PROPN
dhrp-37	43	9	variant	variant	NOUN
dhrp-37	43	10	has	have	AUX
dhrp-37	43	11	also	also	ADV
dhrp-37	43	12	been	be	AUX
dhrp-37	43	13	predicted	predict	VERB
dhrp-37	43	14	by	by	ADP
dhrp-37	43	15	artificial	artificial	ADJ
dhrp-37	43	16	intelligence	intelligence	NOUN
dhrp-37	43	17	models	model	NOUN
dhrp-37	43	18	that	that	PRON
dhrp-37	43	19	have	have	AUX
dhrp-37	43	20	been	be	AUX
dhrp-37	43	21	extensively	extensively	ADV
dhrp-37	43	22	validated	validate	VERB
dhrp-37	43	23	(	(	PUNCT
dhrp-37	43	24	14	14	NUM
dhrp-37	43	25	)	)	PUNCT
dhrp-37	43	26	.	.	PUNCT
dhrp-37	44	1	based	base	VERB
dhrp-37	44	2	on	on	ADP
dhrp-37	44	3	132	132	NUM
dhrp-37	44	4	threedimensional	threedimensional	ADJ
dhrp-37	44	5	structures	structure	NOUN
dhrp-37	44	6	of	of	ADP
dhrp-37	44	7	antibody	antibody	NOUN
dhrp-37	44	8	-	-	PUNCT
dhrp-37	44	9	receptor	receptor	NOUN
dhrp-37	44	10	binding	bind	VERB
dhrp-37	44	11	complexes	complex	NOUN
dhrp-37	44	12	,	,	PUNCT
dhrp-37	44	13	it	it	PRON
dhrp-37	44	14	was	be	AUX
dhrp-37	44	15	suggested	suggest	VERB
dhrp-37	44	16	that	that	SCONJ
dhrp-37	44	17	omicron	omicron	PROPN
dhrp-37	44	18	may	may	AUX
dhrp-37	44	19	be	be	AUX
dhrp-37	44	20	twice	twice	ADV
dhrp-37	44	21	more	more	ADV
dhrp-37	44	22	likely	likely	ADJ
dhrp-37	44	23	to	to	PART
dhrp-37	44	24	escape	escape	VERB
dhrp-37	44	25	current	current	ADJ
dhrp-37	44	26	vaccines	vaccine	NOUN
dhrp-37	44	27	as	as	ADP
dhrp-37	44	28	compared	compare	VERB
dhrp-37	44	29	to	to	ADP
dhrp-37	44	30	the	the	DET
dhrp-37	44	31	delta	delta	NOUN
dhrp-37	44	32	variant	variant	NOUN
dhrp-37	44	33	.	.	PUNCT
dhrp-37	45	1	in	in	ADP
dhrp-37	45	2	an	an	DET
dhrp-37	45	3	independent	independent	ADJ
dhrp-37	45	4	study	study	NOUN
dhrp-37	45	5	,	,	PUNCT
dhrp-37	45	6	pfizer	pfizer	NOUN
dhrp-37	45	7	has	have	AUX
dhrp-37	45	8	claimed	claim	VERB
dhrp-37	45	9	that	that	SCONJ
dhrp-37	45	10	three	three	NUM
dhrp-37	45	11	doses	dose	NOUN
dhrp-37	45	12	of	of	ADP
dhrp-37	45	13	pfizer	pfizer	NOUN
dhrp-37	45	14	-	-	PUNCT
dhrp-37	45	15	biontech	biontech	NOUN
dhrp-37	45	16	covid-19	covid-19	PROPN
dhrp-37	45	17	vaccine	vaccine	NOUN
dhrp-37	45	18	(	(	PUNCT
dhrp-37	45	19	group	group	NOUN
dhrp-37	45	20	b	b	PROPN
dhrp-37	45	21	,	,	PUNCT
dhrp-37	45	22	figure	figure	NOUN
dhrp-37	45	23	1	1	NUM
dhrp-37	45	24	)	)	PUNCT
dhrp-37	45	25	effectively	effectively	ADV
dhrp-37	45	26	neutralized	neutralize	VERB
dhrp-37	45	27	the	the	DET
dhrp-37	45	28	omicron	omicron	PROPN
dhrp-37	45	29	variant	variant	NOUN
dhrp-37	45	30	while	while	SCONJ
dhrp-37	45	31	two	two	NUM
dhrp-37	45	32	doses	dose	NOUN
dhrp-37	45	33	(	(	PUNCT
dhrp-37	45	34	group	group	NOUN
dhrp-37	45	35	a	a	NOUN
dhrp-37	45	36	,	,	PUNCT
dhrp-37	45	37	figure	figure	NOUN
dhrp-37	45	38	1	1	NUM
dhrp-37	45	39	)	)	PUNCT
dhrp-37	45	40	showed	show	VERB
dhrp-37	45	41	significantly	significantly	ADV
dhrp-37	45	42	reduced	reduce	VERB
dhrp-37	45	43	neutralization	neutralization	NOUN
dhrp-37	45	44	titers	titer	NOUN
dhrp-37	45	45	(	(	PUNCT
dhrp-37	45	46	15	15	NUM
dhrp-37	45	47	)	)	PUNCT
dhrp-37	45	48	.	.	PUNCT
dhrp-37	46	1	additionally	additionally	ADV
dhrp-37	46	2	,	,	PUNCT
dhrp-37	46	3	the	the	DET
dhrp-37	46	4	data	datum	NOUN
dhrp-37	46	5	also	also	ADV
dhrp-37	46	6	indicated	indicate	VERB
dhrp-37	46	7	that	that	SCONJ
dhrp-37	46	8	the	the	DET
dhrp-37	46	9	third	third	ADJ
dhrp-37	46	10	dose	dose	NOUN
dhrp-37	46	11	of	of	ADP
dhrp-37	46	12	the	the	DET
dhrp-37	46	13	pfizer	pfizer	NOUN
dhrp-37	46	14	/	/	SYM
dhrp-37	46	15	biontech	biontech	PROPN
dhrp-37	46	16	covid-19	covid-19	PROPN
dhrp-37	46	17	vaccine	vaccine	NOUN
dhrp-37	46	18	increased	increase	VERB
dhrp-37	46	19	the	the	DET
dhrp-37	46	20	neutralizing	neutralizing	ADJ
dhrp-37	46	21	antibody	antibody	NOUN
dhrp-37	46	22	titers	titer	NOUN
dhrp-37	46	23	by	by	ADP
dhrp-37	46	24	25	25	NUM
dhrp-37	46	25	-	-	NOUN
dhrp-37	46	26	fold	fold	VERB
dhrp-37	46	27	as	as	SCONJ
dhrp-37	46	28	compared	compare	VERB
dhrp-37	46	29	to	to	ADP
dhrp-37	46	30	two	two	NUM
dhrp-37	46	31	doses	dose	NOUN
dhrp-37	46	32	against	against	ADP
dhrp-37	46	33	the	the	DET
dhrp-37	46	34	omicron	omicron	PROPN
dhrp-37	46	35	variant	variant	NOUN
dhrp-37	46	36	.	.	PUNCT
dhrp-37	47	1	from	from	ADP
dhrp-37	47	2	the	the	DET
dhrp-37	47	3	foregoing	forego	VERB
dhrp-37	47	4	scientific	scientific	ADJ
dhrp-37	47	5	evidence	evidence	NOUN
dhrp-37	47	6	,	,	PUNCT
dhrp-37	47	7	we	we	PRON
dhrp-37	47	8	conclude	conclude	VERB
dhrp-37	47	9	that	that	PRON
dhrp-37	47	10	to	to	PART
dhrp-37	47	11	afford	afford	VERB
dhrp-37	47	12	effective	effective	ADJ
dhrp-37	47	13	protection	protection	NOUN
dhrp-37	47	14	against	against	ADP
dhrp-37	47	15	various	various	ADJ
dhrp-37	47	16	variants	variant	NOUN
dhrp-37	47	17	of	of	ADP
dhrp-37	47	18	the	the	DET
dhrp-37	47	19	sars	sar	NOUN
dhrp-37	47	20	-	-	PUNCT
dhrp-37	47	21	cov-2	cov-2	NOUN
dhrp-37	47	22	,	,	PUNCT
dhrp-37	47	23	at	at	ADP
dhrp-37	47	24	a	a	DET
dhrp-37	47	25	minimum	minimum	ADJ
dhrp-37	47	26	three	three	NUM
dhrp-37	47	27	doses	dose	NOUN
dhrp-37	47	28	of	of	ADP
dhrp-37	47	29	pfizer	pfizer	NOUN
dhrp-37	47	30	or	or	CCONJ
dhrp-37	47	31	moderna	moderna	PROPN
dhrp-37	47	32	and	and	CCONJ
dhrp-37	47	33	two	two	NUM
dhrp-37	47	34	doses	dose	NOUN
dhrp-37	47	35	of	of	ADP
dhrp-37	47	36	jansen	jansen	PROPN
dhrp-37	47	37	vaccine	vaccine	NOUN
dhrp-37	47	38	would	would	AUX
dhrp-37	47	39	be	be	AUX
dhrp-37	47	40	required	require	VERB
dhrp-37	47	41	.	.	PUNCT
dhrp-37	48	1	in	in	ADP
dhrp-37	48	2	fact	fact	NOUN
dhrp-37	48	3	,	,	PUNCT
dhrp-37	48	4	we	we	PRON
dhrp-37	48	5	had	have	AUX
dhrp-37	48	6	previously	previously	ADV
dhrp-37	48	7	argued	argue	VERB
dhrp-37	48	8	that	that	SCONJ
dhrp-37	48	9	the	the	DET
dhrp-37	48	10	pfizer	pfizer	NOUN
dhrp-37	48	11	/	/	SYM
dhrp-37	48	12	biontech	biontech	PROPN
dhrp-37	48	13	or	or	CCONJ
dhrp-37	48	14	moderna	moderna	PROPN
dhrp-37	48	15	covid-19	covid-19	PROPN
dhrp-37	48	16	vaccines	vaccine	NOUN
dhrp-37	48	17	should	should	AUX
dhrp-37	48	18	have	have	AUX
dhrp-37	48	19	been	be	AUX
dhrp-37	48	20	authorized	authorize	VERB
dhrp-37	48	21	by	by	ADP
dhrp-37	48	22	the	the	DET
dhrp-37	48	23	fda	fda	PROPN
dhrp-37	48	24	as	as	ADP
dhrp-37	48	25	a	a	DET
dhrp-37	48	26	three	three	NUM
dhrp-37	48	27	dose	dose	ADJ
dhrp-37	48	28	primary	primary	ADJ
dhrp-37	48	29	vaccination	vaccination	NOUN
dhrp-37	48	30	series	series	NOUN
dhrp-37	48	31	.	.	PUNCT
dhrp-37	49	1	likewise	likewise	ADV
dhrp-37	49	2	,	,	PUNCT
dhrp-37	49	3	we	we	PRON
dhrp-37	49	4	had	have	AUX
dhrp-37	49	5	also	also	ADV
dhrp-37	49	6	previously	previously	ADV
dhrp-37	49	7	suggested	suggest	VERB
dhrp-37	49	8	that	that	SCONJ
dhrp-37	49	9	jansen	jansen	PROPN
dhrp-37	49	10	covid-19	covid-19	PROPN
dhrp-37	49	11	vaccine	vaccine	NOUN
dhrp-37	49	12	should	should	AUX
dhrp-37	49	13	have	have	AUX
dhrp-37	49	14	been	be	AUX
dhrp-37	49	15	a	a	DET
dhrp-37	49	16	two	two	NUM
dhrp-37	49	17	dose	dose	ADJ
dhrp-37	49	18	primary	primary	ADJ
dhrp-37	49	19	vaccination	vaccination	NOUN
dhrp-37	49	20	series	series	NOUN
dhrp-37	49	21	.	.	PUNCT
dhrp-37	50	1	considering	consider	VERB
dhrp-37	50	2	the	the	DET
dhrp-37	50	3	available	available	ADJ
dhrp-37	50	4	data	datum	NOUN
dhrp-37	50	5	,	,	PUNCT
dhrp-37	50	6	we	we	PRON
dhrp-37	50	7	are	be	AUX
dhrp-37	50	8	also	also	ADV
dhrp-37	50	9	recommending	recommend	VERB
dhrp-37	50	10	that	that	SCONJ
dhrp-37	50	11	booster	booster	NOUN
dhrp-37	50	12	dose	dose	NOUN
dhrp-37	50	13	should	should	AUX
dhrp-37	50	14	be	be	AUX
dhrp-37	50	15	authorized	authorize	VERB
dhrp-37	50	16	for	for	ADP
dhrp-37	50	17	children	child	NOUN
dhrp-37	50	18	5	5	NUM
dhrp-37	50	19	-	-	SYM
dhrp-37	50	20	15	15	NUM
dhrp-37	50	21	years	year	NOUN
dhrp-37	50	22	of	of	ADP
dhrp-37	50	23	age	age	NOUN
dhrp-37	50	24	ensuring	ensure	VERB
dhrp-37	50	25	that	that	SCONJ
dhrp-37	50	26	they	they	PRON
dhrp-37	50	27	are	be	AUX
dhrp-37	50	28	also	also	ADV
dhrp-37	50	29	protected	protect	VERB
dhrp-37	50	30	against	against	ADP
dhrp-37	50	31	the	the	DET
dhrp-37	50	32	sars	sar	NOUN
dhrp-37	50	33	-	-	PUNCT
dhrp-37	50	34	cov-2	cov-2	NOUN
dhrp-37	50	35	variants	variant	NOUN
dhrp-37	50	36	.	.	PUNCT
dhrp-37	51	1	lastly	lastly	ADV
dhrp-37	51	2	,	,	PUNCT
dhrp-37	51	3	we	we	PRON
dhrp-37	51	4	are	be	AUX
dhrp-37	51	5	also	also	ADV
dhrp-37	51	6	recommending	recommend	VERB
dhrp-37	51	7	that	that	SCONJ
dhrp-37	51	8	the	the	DET
dhrp-37	51	9	definition	definition	NOUN
dhrp-37	51	10	of	of	ADP
dhrp-37	51	11	fully	fully	ADV
dhrp-37	51	12	vaccinated	vaccinate	VERB
dhrp-37	51	13	be	be	AUX
dhrp-37	51	14	revised	revise	VERB
dhrp-37	51	15	to	to	PART
dhrp-37	51	16	include	include	VERB
dhrp-37	51	17	three	three	NUM
dhrp-37	51	18	doses	dose	NOUN
dhrp-37	51	19	of	of	ADP
dhrp-37	51	20	pfizer	pfizer	NOUN
dhrp-37	51	21	/	/	SYM
dhrp-37	51	22	biontech	biontech	PROPN
dhrp-37	51	23	or	or	CCONJ
dhrp-37	51	24	moderna	moderna	PROPN
dhrp-37	51	25	and	and	CCONJ
dhrp-37	51	26	two	two	NUM
dhrp-37	51	27	doses	dose	NOUN
dhrp-37	51	28	of	of	ADP
dhrp-37	51	29	jansen	jansen	PROPN
dhrp-37	51	30	covid-19	covid-19	PROPN
dhrp-37	51	31	vaccines	vaccine	NOUN
dhrp-37	51	32	.	.	PUNCT
dhrp-37	52	1	it	it	PRON
dhrp-37	52	2	is	be	AUX
dhrp-37	52	3	not	not	PART
dhrp-37	52	4	entirely	entirely	ADV
dhrp-37	52	5	inconceivable	inconceivable	ADJ
dhrp-37	52	6	that	that	SCONJ
dhrp-37	52	7	in	in	ADP
dhrp-37	52	8	the	the	DET
dhrp-37	52	9	very	very	ADV
dhrp-37	52	10	near	near	ADJ
dhrp-37	52	11	future	future	NOUN
dhrp-37	52	12	,	,	PUNCT
dhrp-37	52	13	we	we	PRON
dhrp-37	52	14	may	may	AUX
dhrp-37	52	15	require	require	VERB
dhrp-37	52	16	additional	additional	ADJ
dhrp-37	52	17	doses	dose	NOUN
dhrp-37	52	18	of	of	ADP
dhrp-37	52	19	covid-19	covid-19	PROPN
dhrp-37	52	20	vaccine	vaccine	NOUN
dhrp-37	52	21	that	that	PRON
dhrp-37	52	22	has	have	AUX
dhrp-37	52	23	been	be	AUX
dhrp-37	52	24	tailored	tailor	VERB
dhrp-37	52	25	to	to	PART
dhrp-37	52	26	neutralize	neutralize	VERB
dhrp-37	52	27	evolving	evolve	VERB
dhrp-37	52	28	sars	sar	NOUN
dhrp-37	52	29	-	-	PUNCT
dhrp-37	52	30	cov-2	cov-2	NOUN
dhrp-37	52	31	variants	variant	NOUN
dhrp-37	52	32	.	.	PUNCT
dhrp-37	53	1	figure	figure	NOUN
dhrp-37	53	2	1	1	NUM
dhrp-37	53	3	:	:	PUNCT
dhrp-37	53	4	experimental	experimental	ADJ
dhrp-37	53	5	design	design	NOUN
dhrp-37	53	6	to	to	PART
dhrp-37	53	7	determine	determine	VERB
dhrp-37	53	8	the	the	DET
dhrp-37	53	9	capacity	capacity	NOUN
dhrp-37	53	10	of	of	ADP
dhrp-37	53	11	antibodies	antibody	NOUN
dhrp-37	53	12	to	to	PART
dhrp-37	53	13	neutralize	neutralize	VERB
dhrp-37	53	14	omicron	omicron	PROPN
dhrp-37	53	15	(	(	PUNCT
dhrp-37	53	16	b.1.1.529	b.1.1.529	ADV
dhrp-37	53	17	)	)	PUNCT
dhrp-37	53	18	variant	variant	NOUN
dhrp-37	53	19	of	of	ADP
dhrp-37	53	20	sars	sar	NOUN
dhrp-37	53	21	-	-	PUNCT
dhrp-37	53	22	cov-2	cov-2	NOUN
dhrp-37	53	23	in	in	ADP
dhrp-37	53	24	subjects	subject	NOUN
dhrp-37	53	25	vaccinated	vaccinate	VERB
dhrp-37	53	26	with	with	ADP
dhrp-37	53	27	two	two	NUM
dhrp-37	53	28	doses	dose	NOUN
dhrp-37	53	29	(	(	PUNCT
dhrp-37	53	30	group	group	NOUN
dhrp-37	53	31	a	a	NOUN
dhrp-37	53	32	)	)	PUNCT
dhrp-37	53	33	or	or	CCONJ
dhrp-37	53	34	three	three	NUM
dhrp-37	53	35	doses	dose	NOUN
dhrp-37	53	36	(	(	PUNCT
dhrp-37	53	37	group	group	NOUN
dhrp-37	53	38	b	b	NOUN
dhrp-37	53	39	)	)	PUNCT
dhrp-37	53	40	of	of	ADP
dhrp-37	53	41	pfizer	pfizer	NOUN
dhrp-37	53	42	/	/	SYM
dhrp-37	53	43	biontech	biontech	NOUN
dhrp-37	53	44	vaccine	vaccine	NOUN
dhrp-37	53	45	diclosures	diclosure	VERB
dhrp-37	53	46	sr	sr	PROPN
dhrp-37	53	47	declares	declare	VERB
dhrp-37	53	48	no	no	DET
dhrp-37	53	49	conflicts	conflict	NOUN
dhrp-37	53	50	of	of	ADP
dhrp-37	53	51	interest	interest	NOUN
dhrp-37	53	52	.	.	PUNCT
dhrp-37	54	1	ms	ms	PROPN
dhrp-37	54	2	declares	declare	VERB
dhrp-37	54	3	no	no	DET
dhrp-37	54	4	conflicts	conflict	NOUN
dhrp-37	54	5	of	of	ADP
dhrp-37	54	6	interest	interest	NOUN
dhrp-37	54	7	.	.	PUNCT
dhrp-37	55	1	references	reference	NOUN
dhrp-37	55	2	1	1	NUM
dhrp-37	55	3	.	.	X
dhrp-37	55	4	who	who	PRON
dhrp-37	55	5	coronavirus	coronavirus	VERB
dhrp-37	55	6	(	(	PUNCT
dhrp-37	55	7	covid-19	covid-19	PROPN
dhrp-37	55	8	)	)	PUNCT
dhrp-37	55	9	dashboard	dashboard	NOUN
dhrp-37	55	10	.	.	PUNCT
dhrp-37	56	1	https://covid19.who.int/	https://covid19.who.int/	PROPN
dhrp-37	57	1	(	(	PUNCT
dhrp-37	57	2	accessed	access	VERB
dhrp-37	57	3	on	on	ADP
dhrp-37	57	4	december	december	PROPN
dhrp-37	57	5	09	09	NUM
dhrp-37	57	6	,	,	PUNCT
dhrp-37	57	7	2021	2021	NUM
dhrp-37	57	8	;	;	PUNCT
dhrp-37	57	9	15:40	15:40	NUM
dhrp-37	57	10	hrs	hrs	NOUN
dhrp-37	57	11	)	)	PUNCT
dhrp-37	57	12	2	2	NUM
dhrp-37	57	13	.	.	X
dhrp-37	57	14	covid	covid	PROPN
dhrp-37	57	15	data	data	PROPN
dhrp-37	57	16	tracker	tracker	PROPN
dhrp-37	57	17	.	.	PUNCT
dhrp-37	58	1	centers	center	NOUN
dhrp-37	58	2	for	for	ADP
dhrp-37	58	3	disease	disease	NOUN
dhrp-37	58	4	control	control	NOUN
dhrp-37	58	5	and	and	CCONJ
dhrp-37	58	6	prevention	prevention	NOUN
dhrp-37	58	7	.	.	PUNCT
dhrp-37	59	1	cdc	cdc	PROPN
dhrp-37	59	2	data	data	PROPN
dhrp-37	59	3	tracker	tracker	PROPN
dhrp-37	59	4	.	.	PUNCT
dhrp-37	60	1	(	(	PUNCT
dhrp-37	60	2	accessed	access	VERB
dhrp-37	60	3	on	on	ADP
dhrp-37	60	4	december	december	PROPN
dhrp-37	60	5	09	09	NUM
dhrp-37	60	6	,	,	PUNCT
dhrp-37	60	7	2021	2021	NUM
dhrp-37	60	8	;	;	PUNCT
dhrp-37	60	9	15:50	15:50	NUM
dhrp-37	60	10	hrs	hrs	NOUN
dhrp-37	60	11	)	)	PUNCT
dhrp-37	60	12	https://covid19.who.int/	https://covid19.who.int/	NOUN
dhrp-37	61	1	https://covid.cdc.gov/covid-data-tracker/#datatracker-home	https://covid.cdc.gov/covid-data-tracker/#datatracker-home	INTJ
dhrp-37	61	2	dhrp	dhrp	ADJ
dhrp-37	61	3	,	,	PUNCT
dhrp-37	61	4	2021	2021	NUM
dhrp-37	61	5	,	,	PUNCT
dhrp-37	61	6	vol	vol	NOUN
dhrp-37	61	7	.	.	NOUN
dhrp-37	61	8	1	1	NUM
dhrp-37	61	9	(	(	PUNCT
dhrp-37	61	10	s5	s5	NOUN
dhrp-37	61	11	)	)	PUNCT
dhrp-37	61	12	11	11	NUM
dhrp-37	61	13	-	-	SYM
dhrp-37	61	14	14	14	NUM
dhrp-37	61	15	definition	definition	NOUN
dhrp-37	61	16	of	of	ADP
dhrp-37	61	17	fully	fully	ADV
dhrp-37	61	18	vaccinated	vaccinate	VERB
dhrp-37	61	19	?	?	PUNCT
dhrp-37	62	1	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-37	62	2	14	14	NUM
dhrp-37	62	3	©	©	PROPN
dhrp-37	62	4	dhr	dhr	PROPN
dhrp-37	62	5	health	health	PROPN
dhrp-37	62	6	institute	institute	PROPN
dhrp-37	62	7	for	for	ADP
dhrp-37	62	8	research	research	NOUN
dhrp-37	62	9	and	and	CCONJ
dhrp-37	62	10	development	development	NOUN
dhrp-37	62	11	3	3	NUM
dhrp-37	62	12	.	.	PUNCT
dhrp-37	62	13	chemaitelly	chemaitelly	ADV
dhrp-37	62	14	h	h	PROPN
dhrp-37	62	15	,	,	PUNCT
dhrp-37	62	16	tang	tang	X
dhrp-37	62	17	p	p	X
dhrp-37	62	18	,	,	PUNCT
dhrp-37	62	19	hasan	hasan	PROPN
dhrp-37	62	20	mr	mr	PROPN
dhrp-37	62	21	,	,	PUNCT
dhrp-37	62	22	et	et	PROPN
dhrp-37	62	23	.	.	PUNCT
dhrp-37	63	1	al	al	PROPN
dhrp-37	63	2	.	.	PROPN
dhrp-37	63	3	waning	wane	VERB
dhrp-37	63	4	of	of	ADP
dhrp-37	63	5	bnt162b2	bnt162b2	NOUN
dhrp-37	63	6	vaccine	vaccine	NOUN
dhrp-37	63	7	protection	protection	NOUN
dhrp-37	63	8	against	against	ADP
dhrp-37	63	9	sars	sar	NOUN
dhrp-37	63	10	-	-	PUNCT
dhrp-37	63	11	cov-2	cov-2	PART
dhrp-37	63	12	infection	infection	NOUN
dhrp-37	63	13	in	in	ADP
dhrp-37	63	14	qatar	qatar	PROPN
dhrp-37	63	15	.	.	PUNCT
dhrp-37	64	1	n.	n.	PROPN
dhrp-37	64	2	engl	engl	PROPN
dhrp-37	64	3	j	j	PROPN
dhrp-37	64	4	med	med	PROPN
dhrp-37	64	5	2021	2021	NUM
dhrp-37	64	6	;	;	PUNCT
dhrp-37	64	7	385	385	NUM
dhrp-37	64	8	:	:	PUNCT
dhrp-37	64	9	e83	e83	NOUN
dhrp-37	64	10	.	.	PUNCT
dhrp-37	65	1	doi	doi	NOUN
dhrp-37	65	2	:	:	PUNCT
dhrp-37	65	3	10.1056	10.1056	NUM
dhrp-37	65	4	/	/	SYM
dhrp-37	65	5	nejmoa2114114	nejmoa2114114	PROPN
dhrp-37	65	6	4	4	NUM
dhrp-37	65	7	.	.	PUNCT
dhrp-37	66	1	levin	levin	PROPN
dhrp-37	66	2	eg	eg	PROPN
dhrp-37	66	3	,	,	PUNCT
dhrp-37	66	4	lustig	lustig	PROPN
dhrp-37	66	5	y	y	PROPN
dhrp-37	66	6	,	,	PUNCT
dhrp-37	66	7	cohen	cohen	PROPN
dhrp-37	66	8	c	c	PROPN
dhrp-37	66	9	,	,	PUNCT
dhrp-37	66	10	et	et	PROPN
dhrp-37	66	11	.	.	PUNCT
dhrp-37	67	1	al	al	PROPN
dhrp-37	67	2	.	.	PROPN
dhrp-37	67	3	waning	wane	VERB
dhrp-37	67	4	immune	immune	ADJ
dhrp-37	67	5	humoral	humoral	ADJ
dhrp-37	67	6	responses	response	NOUN
dhrp-37	67	7	to	to	ADP
dhrp-37	67	8	bnt162b2	bnt162b2	VERB
dhrp-37	67	9	covid-19	covid-19	PROPN
dhrp-37	67	10	vaccine	vaccine	NOUN
dhrp-37	67	11	over	over	ADP
dhrp-37	67	12	6	6	NUM
dhrp-37	67	13	months	month	NOUN
dhrp-37	67	14	.	.	PUNCT
dhrp-37	68	1	n.	n.	PROPN
dhrp-37	68	2	eng	eng	PROPN
dhrp-37	68	3	j	j	PROPN
dhrp-37	68	4	med	med	PROPN
dhrp-37	68	5	2021	2021	NUM
dhrp-37	68	6	;	;	PUNCT
dhrp-37	68	7	385	385	NUM
dhrp-37	68	8	:	:	PUNCT
dhrp-37	68	9	e84	e84	PROPN
dhrp-37	68	10	doi	doi	NOUN
dhrp-37	68	11	:	:	PUNCT
dhrp-37	68	12	10.1056	10.1056	NUM
dhrp-37	68	13	/	/	SYM
dhrp-37	68	14	nejmoa2114583	nejmoa2114583	PROPN
dhrp-37	68	15	5	5	NUM
dhrp-37	68	16	.	.	PUNCT
dhrp-37	68	17	bar	bar	NOUN
dhrp-37	68	18	-	-	PUNCT
dhrp-37	68	19	on	on	ADP
dhrp-37	68	20	ym	ym	PROPN
dhrp-37	68	21	,	,	PUNCT
dhrp-37	68	22	goldberg	goldberg	PROPN
dhrp-37	68	23	y	y	PROPN
dhrp-37	68	24	,	,	PUNCT
dhrp-37	68	25	mandel	mandel	PROPN
dhrp-37	68	26	m	m	PROPN
dhrp-37	68	27	,	,	PUNCT
dhrp-37	68	28	et.al	et.al	PROPN
dhrp-37	68	29	.	.	PUNCT
dhrp-37	69	1	protection	protection	NOUN
dhrp-37	69	2	of	of	ADP
dhrp-37	69	3	bnt162b2	bnt162b2	NOUN
dhrp-37	69	4	vaccine	vaccine	NOUN
dhrp-37	69	5	booster	booster	NOUN
dhrp-37	69	6	against	against	ADP
dhrp-37	69	7	covid-19	covid-19	PROPN
dhrp-37	69	8	in	in	ADP
dhrp-37	69	9	israel	israel	PROPN
dhrp-37	69	10	.	.	PUNCT
dhrp-37	70	1	n	n	PROPN
dhrp-37	70	2	engl	engl	PROPN
dhrp-37	70	3	j	j	PROPN
dhrp-37	70	4	med	med	PROPN
dhrp-37	70	5	2021	2021	NUM
dhrp-37	70	6	;	;	PUNCT
dhrp-37	70	7	385:1393	385:1393	NUM
dhrp-37	70	8	-	-	SYM
dhrp-37	70	9	1400	1400	NUM
dhrp-37	70	10	doi	doi	NOUN
dhrp-37	70	11	:	:	PUNCT
dhrp-37	70	12	10.1056	10.1056	NUM
dhrp-37	70	13	/	/	SYM
dhrp-37	70	14	nejmoa2114255	nejmoa2114255	PROPN
dhrp-37	70	15	6	6	NUM
dhrp-37	70	16	.	.	PUNCT
dhrp-37	71	1	barda	barda	PROPN
dhrp-37	71	2	n	n	CCONJ
dhrp-37	71	3	,	,	PUNCT
dhrp-37	71	4	dagan	dagan	PROPN
dhrp-37	71	5	n	n	CCONJ
dhrp-37	71	6	,	,	PUNCT
dhrp-37	71	7	cohen	cohen	PROPN
dhrp-37	71	8	c	c	PROPN
dhrp-37	71	9	,	,	PUNCT
dhrp-37	71	10	et.al	et.al	PROPN
dhrp-37	71	11	.	.	PUNCT
dhrp-37	71	12	effectiveness	effectiveness	NOUN
dhrp-37	71	13	of	of	ADP
dhrp-37	71	14	a	a	DET
dhrp-37	71	15	third	third	ADJ
dhrp-37	71	16	dose	dose	NOUN
dhrp-37	71	17	of	of	ADP
dhrp-37	71	18	the	the	DET
dhrp-37	71	19	bnt162b2	bnt162b2	PROPN
dhrp-37	71	20	mrna	mrna	PROPN
dhrp-37	71	21	covid-19	covid-19	PROPN
dhrp-37	71	22	vaccine	vaccine	NOUN
dhrp-37	71	23	for	for	ADP
dhrp-37	71	24	preventing	prevent	VERB
dhrp-37	71	25	severe	severe	ADJ
dhrp-37	71	26	outcomes	outcome	NOUN
dhrp-37	71	27	in	in	ADP
dhrp-37	71	28	israel	israel	PROPN
dhrp-37	71	29	:	:	PUNCT
dhrp-37	71	30	an	an	DET
dhrp-37	71	31	observational	observational	ADJ
dhrp-37	71	32	study	study	NOUN
dhrp-37	71	33	.	.	PUNCT
dhrp-37	72	1	lancet	lancet	PROPN
dhrp-37	72	2	2021	2021	NUM
dhrp-37	72	3	;	;	PUNCT
dhrp-37	72	4	398	398	NUM
dhrp-37	72	5	:	:	PUNCT
dhrp-37	72	6	2093	2093	NUM
dhrp-37	72	7	-	-	SYM
dhrp-37	72	8	100	100	NUM
dhrp-37	72	9	.	.	PUNCT
dhrp-37	73	1	doi	doi	NOUN
dhrp-37	73	2	:	:	PUNCT
dhrp-37	73	3	10.1016	10.1016	NUM
dhrp-37	73	4	/	/	SYM
dhrp-37	73	5	s0140	s0140	PROPN
dhrp-37	73	6	-	-	PUNCT
dhrp-37	73	7	6736(21)02249	6736(21)02249	NUM
dhrp-37	73	8	-	-	PUNCT
dhrp-37	73	9	2	2	NUM
dhrp-37	73	10	7	7	NUM
dhrp-37	73	11	.	.	PUNCT
dhrp-37	73	12	coronavirus	coronavirus	NOUN
dhrp-37	73	13	(	(	PUNCT
dhrp-37	73	14	covid-19	covid-19	PROPN
dhrp-37	73	15	)	)	PUNCT
dhrp-37	73	16	update	update	NOUN
dhrp-37	73	17	:	:	PUNCT
dhrp-37	73	18	fda	fda	PROPN
dhrp-37	73	19	authorizes	authorize	VERB
dhrp-37	73	20	additional	additional	ADJ
dhrp-37	73	21	vaccine	vaccine	NOUN
dhrp-37	73	22	dose	dose	VERB
dhrp-37	73	23	for	for	ADP
dhrp-37	73	24	certain	certain	ADJ
dhrp-37	73	25	immunocompromised	immunocompromise	VERB
dhrp-37	73	26	individuals	individual	NOUN
dhrp-37	73	27	.	.	PUNCT
dhrp-37	74	1	aug	aug	PROPN
dhrp-37	74	2	12	12	NUM
dhrp-37	74	3	,	,	PUNCT
dhrp-37	74	4	2021	2021	NUM
dhrp-37	74	5	.	.	PUNCT
dhrp-37	75	1	fda	fda	PROPN
dhrp-37	75	2	news	news	PROPN
dhrp-37	75	3	release	release	NOUN
dhrp-37	75	4	.	.	PUNCT
dhrp-37	76	1	8	8	X
dhrp-37	76	2	.	.	PUNCT
dhrp-37	77	1	cdc	cdc	PROPN
dhrp-37	77	2	expands	expand	VERB
dhrp-37	77	3	eligibility	eligibility	NOUN
dhrp-37	77	4	for	for	ADP
dhrp-37	77	5	covid-19	covid-19	PROPN
dhrp-37	77	6	booster	booster	NOUN
dhrp-37	77	7	shots	shot	VERB
dhrp-37	77	8	to	to	ADP
dhrp-37	77	9	all	all	DET
dhrp-37	77	10	adults	adult	NOUN
dhrp-37	77	11	.	.	PUNCT
dhrp-37	78	1	nov	nov	PROPN
dhrp-37	78	2	19	19	NUM
dhrp-37	78	3	,	,	PUNCT
dhrp-37	78	4	2021	2021	NUM
dhrp-37	78	5	.	.	PUNCT
dhrp-37	79	1	cdc	cdc	PROPN
dhrp-37	79	2	news	news	PROPN
dhrp-37	79	3	release	release	NOUN
dhrp-37	79	4	.	.	PUNCT
dhrp-37	80	1	9	9	X
dhrp-37	80	2	.	.	X
dhrp-37	80	3	coronavirus	coronavirus	NOUN
dhrp-37	80	4	(	(	PUNCT
dhrp-37	80	5	covid-19	covid-19	PROPN
dhrp-37	80	6	)	)	PUNCT
dhrp-37	80	7	update	update	NOUN
dhrp-37	80	8	:	:	PUNCT
dhrp-37	80	9	fda	fda	PROPN
dhrp-37	80	10	expands	expand	VERB
dhrp-37	80	11	eligibility	eligibility	NOUN
dhrp-37	80	12	for	for	SCONJ
dhrp-37	80	13	pfizer	pfizer	NOUN
dhrp-37	80	14	-	-	PUNCT
dhrp-37	80	15	biontech	biontech	NOUN
dhrp-37	80	16	covid-19	covid-19	PROPN
dhrp-37	80	17	booster	booster	NOUN
dhrp-37	80	18	dose	dose	VERB
dhrp-37	80	19	to	to	ADP
dhrp-37	80	20	16	16	NUM
dhrp-37	80	21	and	and	CCONJ
dhrp-37	80	22	17	17	NUM
dhrp-37	80	23	year	year	NOUN
dhrp-37	80	24	olds	old	NOUN
dhrp-37	80	25	.	.	PUNCT
dhrp-37	81	1	dec	dec	PROPN
dhrp-37	81	2	09	09	NUM
dhrp-37	81	3	,	,	PUNCT
dhrp-37	81	4	2021	2021	NUM
dhrp-37	81	5	.	.	PUNCT
dhrp-37	82	1	fda	fda	PROPN
dhrp-37	82	2	news	news	PROPN
dhrp-37	82	3	release	release	NOUN
dhrp-37	82	4	.	.	PUNCT
dhrp-37	83	1	10	10	NUM
dhrp-37	83	2	.	.	PUNCT
dhrp-37	84	1	cheng	cheng	PROPN
dhrp-37	84	2	,	,	PUNCT
dhrp-37	84	3	m.	m.	NOUN
dhrp-37	84	4	what	what	PRON
dhrp-37	84	5	is	be	AUX
dhrp-37	84	6	this	this	DET
dhrp-37	84	7	new	new	ADJ
dhrp-37	84	8	covid	covid	NOUN
dhrp-37	84	9	variant	variant	NOUN
dhrp-37	84	10	in	in	ADP
dhrp-37	84	11	south	south	PROPN
dhrp-37	84	12	africa	africa	PROPN
dhrp-37	84	13	.	.	PUNCT
dhrp-37	85	1	november	november	PROPN
dhrp-37	85	2	26	26	NUM
dhrp-37	85	3	,	,	PUNCT
dhrp-37	85	4	2021	2021	NUM
dhrp-37	85	5	.	.	PUNCT
dhrp-37	86	1	associated	associated	ADJ
dhrp-37	86	2	press	press	NOUN
dhrp-37	86	3	.	.	PUNCT
dhrp-37	87	1	https://www.aol.com/explainer-covid-variant-southafrica-111307372-142856393.html	https://www.aol.com/explainer-covid-variant-southafrica-111307372-142856393.html	PROPN
dhrp-37	87	2	11	11	NUM
dhrp-37	87	3	.	.	PUNCT
dhrp-37	88	1	classification	classification	NOUN
dhrp-37	88	2	of	of	ADP
dhrp-37	88	3	omicron	omicron	PROPN
dhrp-37	88	4	(	(	PUNCT
dhrp-37	88	5	b.1.1.529	b.1.1.529	ADV
dhrp-37	88	6	):	):	PUNCT
dhrp-37	88	7	sars	sar	NOUN
dhrp-37	88	8	-	-	PUNCT
dhrp-37	88	9	cov-2	cov-2	NOUN
dhrp-37	88	10	variant	variant	NOUN
dhrp-37	88	11	of	of	ADP
dhrp-37	88	12	concern	concern	NOUN
dhrp-37	88	13	.	.	PUNCT
dhrp-37	89	1	world	world	NOUN
dhrp-37	89	2	health	health	PROPN
dhrp-37	89	3	organization	organization	PROPN
dhrp-37	89	4	.	.	PUNCT
dhrp-37	90	1	november	november	PROPN
dhrp-37	90	2	26	26	NUM
dhrp-37	90	3	,	,	PUNCT
dhrp-37	90	4	2021	2021	NUM
dhrp-37	90	5	.	.	PUNCT
dhrp-37	91	1	who	who	PRON
dhrp-37	91	2	statement	statement	VERB
dhrp-37	91	3	12	12	NUM
dhrp-37	91	4	.	.	PUNCT
dhrp-37	92	1	statement	statement	NOUN
dhrp-37	92	2	from	from	ADP
dhrp-37	92	3	president	president	PROPN
dhrp-37	92	4	joe	joe	PROPN
dhrp-37	92	5	biden	biden	PROPN
dhrp-37	92	6	on	on	ADP
dhrp-37	92	7	the	the	DET
dhrp-37	92	8	omicron	omicron	PROPN
dhrp-37	92	9	covid-19	covid-19	PROPN
dhrp-37	92	10	variant	variant	NOUN
dhrp-37	92	11	.	.	PUNCT
dhrp-37	93	1	the	the	DET
dhrp-37	93	2	white	white	PROPN
dhrp-37	93	3	house	house	PROPN
dhrp-37	93	4	.	.	PUNCT
dhrp-37	94	1	november	november	PROPN
dhrp-37	94	2	26	26	NUM
dhrp-37	94	3	,	,	PUNCT
dhrp-37	94	4	2021	2021	NUM
dhrp-37	94	5	.	.	PUNCT
dhrp-37	95	1	whitehouse	whitehouse	NOUN
dhrp-37	95	2	statement	statement	NOUN
dhrp-37	95	3	13	13	NUM
dhrp-37	95	4	.	.	PUNCT
dhrp-37	96	1	cele	cele	PROPN
dhrp-37	96	2	s	s	PROPN
dhrp-37	96	3	,	,	PUNCT
dhrp-37	96	4	jackson	jackson	PROPN
dhrp-37	96	5	l	l	PROPN
dhrp-37	96	6	,	,	PUNCT
dhrp-37	96	7	khan	khan	PROPN
dhrp-37	96	8	k	k	PROPN
dhrp-37	96	9	,	,	PUNCT
dhrp-37	96	10	et.al	et.al	PROPN
dhrp-37	96	11	.	.	PUNCT
dhrp-37	97	1	sars	sars	PROPN
dhrp-37	97	2	-	-	PUNCT
dhrp-37	97	3	cov-2	cov-2	PART
dhrp-37	97	4	omicron	omicron	NOUN
dhrp-37	97	5	has	have	VERB
dhrp-37	97	6	extensive	extensive	ADJ
dhrp-37	97	7	but	but	CCONJ
dhrp-37	97	8	incomplete	incomplete	ADJ
dhrp-37	97	9	escape	escape	NOUN
dhrp-37	97	10	of	of	ADP
dhrp-37	97	11	pfizer	pfizer	NOUN
dhrp-37	97	12	bnt	bnt	PROPN
dhrp-37	97	13	162b2	162b2	NUM
dhrp-37	97	14	elicited	elicit	VERB
dhrp-37	97	15	neutralization	neutralization	NOUN
dhrp-37	97	16	and	and	CCONJ
dhrp-37	97	17	requires	require	VERB
dhrp-37	97	18	ace2	ace2	NOUN
dhrp-37	97	19	for	for	ADP
dhrp-37	97	20	infection	infection	NOUN
dhrp-37	97	21	.	.	PUNCT
dhrp-37	98	1	medrxiv	medrxiv	PROPN
dhrp-37	98	2	2021.12.08.21267417	2021.12.08.21267417	NUM
dhrp-37	98	3	;	;	PUNCT
dhrp-37	98	4	doi	doi	NOUN
dhrp-37	98	5	:	:	PUNCT
dhrp-37	98	6	10.1101/2021.12.08.2126741715	10.1101/2021.12.08.2126741715	PROPN
dhrp-37	98	7	14	14	NUM
dhrp-37	98	8	.	.	PUNCT
dhrp-37	99	1	chen	chen	PROPN
dhrp-37	99	2	j	j	PROPN
dhrp-37	99	3	,	,	PUNCT
dhrp-37	99	4	wang	wang	PROPN
dhrp-37	99	5	r	r	PROPN
dhrp-37	99	6	,	,	PUNCT
dhrp-37	99	7	gilby	gilby	PROPN
dhrp-37	99	8	nb	nb	PROPN
dhrp-37	99	9	,	,	PUNCT
dhrp-37	99	10	wei	wei	PROPN
dhrp-37	99	11	gw	gw	PROPN
dhrp-37	99	12	.	.	PUNCT
dhrp-37	99	13	omicron	omicron	PROPN
dhrp-37	99	14	(	(	PUNCT
dhrp-37	99	15	b.1.1.529	b.1.1.529	ADV
dhrp-37	99	16	):	):	PUNCT
dhrp-37	99	17	infectivity	infectivity	NOUN
dhrp-37	99	18	,	,	PUNCT
dhrp-37	99	19	vaccine	vaccine	NOUN
dhrp-37	99	20	breakthrough	breakthrough	NOUN
dhrp-37	99	21	,	,	PUNCT
dhrp-37	99	22	and	and	CCONJ
dhrp-37	99	23	antibody	antibody	NOUN
dhrp-37	99	24	resistance	resistance	NOUN
dhrp-37	99	25	.	.	PUNCT
dhrp-37	100	1	arxiv	arxiv	NOUN
dhrp-37	101	1	[	[	X
dhrp-37	101	2	preprint	preprint	NOUN
dhrp-37	101	3	]	]	X
dhrp-37	101	4	.	.	PUNCT
dhrp-37	102	1	2021	2021	NUM
dhrp-37	102	2	dec	dec	PROPN
dhrp-37	102	3	1	1	NUM
dhrp-37	102	4	:	:	PUNCT
dhrp-37	102	5	arxiv:2112.01318v1	arxiv:2112.01318v1	X
dhrp-37	102	6	.	.	PUNCT
dhrp-37	103	1	pmid	pmid	NOUN
dhrp-37	103	2	:	:	PUNCT
dhrp-37	103	3	34873578	34873578	NUM
dhrp-37	103	4	;	;	PUNCT
dhrp-37	103	5	pmcid	pmcid	ADJ
dhrp-37	103	6	:	:	PUNCT
dhrp-37	103	7	pmc8647651	pmc8647651	ADJ
dhrp-37	103	8	.	.	PUNCT
dhrp-37	104	1	15	15	X
dhrp-37	104	2	.	.	X
dhrp-37	104	3	pfizer	pfizer	NOUN
dhrp-37	104	4	and	and	CCONJ
dhrp-37	104	5	biontech	biontech	NOUN
dhrp-37	104	6	provide	provide	VERB
dhrp-37	104	7	update	update	NOUN
dhrp-37	104	8	on	on	ADP
dhrp-37	104	9	omicron	omicron	PROPN
dhrp-37	104	10	variant	variant	NOUN
dhrp-37	104	11	.	.	PUNCT
dhrp-37	105	1	dec	dec	PROPN
dhrp-37	105	2	08	08	NUM
dhrp-37	105	3	,	,	PUNCT
dhrp-37	105	4	2021	2021	NUM
dhrp-37	105	5	.	.	PUNCT
dhrp-37	106	1	pfizer	pfizer	NOUN
dhrp-37	106	2	/	/	SYM
dhrp-37	106	3	biontech	biontech	PROPN
dhrp-37	106	4	news	news	NOUN
dhrp-37	106	5	release	release	NOUN
dhrp-37	106	6	https://www.nejm.org/doi/10.1056/nejmoa2114114	https://www.nejm.org/doi/10.1056/nejmoa2114114	PRON
dhrp-37	106	7	https://www.nejm.org/doi/full/10.1056/nejmoa2114583	https://www.nejm.org/doi/full/10.1056/nejmoa2114583	PROPN
dhrp-37	106	8	https://www.nejm.org/doi/10.1056/nejmoa2114255	https://www.nejm.org/doi/10.1056/nejmoa2114255	PROPN
dhrp-37	106	9	https://www.thelancet.com/pdfs/journals/lancet/piis0140-6736(21)02249-2.pdf	https://www.thelancet.com/pdfs/journals/lancet/piis0140-6736(21)02249-2.pdf	PROPN
dhrp-37	106	10	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromise	VERB
dhrp-37	106	11	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromise	VERB
dhrp-37	106	12	https://www.cdc.gov/media/releases/2021/s1119-booster-shots.html	https://www.cdc.gov/media/releases/2021/s1119-booster-shots.html	PROPN
dhrp-37	106	13	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17	PROPN
dhrp-37	106	14	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17	NUM
dhrp-37	106	15	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	PROPN
dhrp-37	106	16	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	https://www.aol.com/explainer-covid-variant-south-africa-111307372-142856393.html	PROPN
dhrp-37	106	17	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern	PROPN
dhrp-37	106	18	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	https://www.whitehouse.gov/briefing-room/statements-releases/2021/11/26/statement-by-president-joe-biden-on-the-omicron-covid-19-variant/	PROPN
dhrp-37	106	19	https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v1	https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v1	NOUN
dhrp-37	106	20	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8647651/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8647651/	PROPN
dhrp-37	106	21	https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant	https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant	NOUN